UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission File No.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of | (I.R.S. Employer |
(Address of Principal Executive Offices, including zip code)
(
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
| Trading |
| Name of each exchange |
The | ||||
The |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer | ☐ | Accelerated filer | ☐ |
☒ | Smaller reporting company | ||
Emerging growth company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes
On August 14, 2024, there were
BINAH CAPITAL GROUP, INC.
Quarterly Report on Form 10-Q
Table of Contents
1 | ||
1 | ||
2 | ||
3 | ||
4 | ||
Notes to Unaudited Condensed Consolidated Financial Statements | 5 | |
Management’s Discussion and Analysis of Financial Condition and Results of Operations | 19 | |
32 | ||
32 | ||
33 | ||
33 | ||
33 | ||
33 | ||
33 | ||
33 | ||
37 | ||
38 |
PART I—FINANCIAL INFORMATION
Item 1. Financial Statements.
BINAH CAPITAL GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION
(in thousands except for share and per share amounts)
Unaudited |
| |||||
June 30, 2024 | December 31, 2023 | |||||
ASSETS | ||||||
Assets: | ||||||
Cash, cash equivalents and restricted cash | $ | | $ | | ||
Receivables: |
|
|
|
| ||
Commission receivable |
| |
| | ||
Due from clearing broker |
| |
| | ||
Other |
| |
| | ||
Property and equipment, net |
| |
| | ||
Right of use asset |
| |
| | ||
Intangible assets, net |
| |
| | ||
Goodwill |
| |
| | ||
Other assets |
| |
| | ||
TOTAL ASSETS | $ | | $ | | ||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
| ||
Liabilities: |
|
|
|
| ||
Accounts payable, accrued expenses and other liabilities | $ | | $ | | ||
Commissions payable |
| |
| | ||
Operating lease liability |
| |
| | ||
Notes payable, net of unamortized debt issuance costs of $ |
| |
| | ||
Promissory notes-affiliates |
| |
| | ||
Due to members |
| — |
| | ||
TOTAL LIABILITIES |
| |
| | ||
Mezzanine Equity: |
|
|
|
| ||
Redeemable Series A Convertible Preferred Stock, par value $ |
| |
| — | ||
Stockholders’ Equity and Members’ Equity: |
|
|
|
| ||
Common stock, $ |
| — |
| — | ||
Additional paid-in-capital |
| |
| — | ||
Accumulated deficit |
| ( |
| — | ||
Members’ equity attributed to Legacy Wentworth Management Services LLC |
| — |
| | ||
Total Stockholders’ Equity, Mezzanine Equity and Members’ Equity Attributable to Wentworth Management Services LLC |
| |
| | ||
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY | $ | | $ | |
The accompanying notes are an integral part of these unaudited condensed financial statements.
1
BINAH CAPITAL GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(in thousands except for share and per share amounts)
| Three Months Ended June 30, |
| Six months ended June 30, | |||||||||
| 2024 |
| 2023 |
| 2024 | 2023 | ||||||
Revenues: | ||||||||||||
Revenue from Contracts with Customers: |
|
|
| |||||||||
Commissions | | | $ | | $ | | ||||||
Advisory fees |
| |
| | | | ||||||
Total Revenue from Contracts with Customers |
| |
| | | | ||||||
Interest and other income |
| |
| | | | ||||||
Total revenues |
| |
| | | | ||||||
Expenses: |
|
|
|
| ||||||||
Commissions and fees |
| |
| | | | ||||||
Employee compensation and benefits |
| |
| | | | ||||||
Rent and occupancy |
| |
| | | | ||||||
Professional fees |
| |
| | | | ||||||
Technology fees |
| |
| | | | ||||||
Interest |
| |
| | | | ||||||
Depreciation and amortization |
| |
| | | | ||||||
Other |
| |
| | | | ||||||
Total expenses |
| |
| | | | ||||||
Income (loss) before provision for income taxes |
| ( |
| | ( | | ||||||
Provision for income taxes |
| |
| | | | ||||||
Net income (loss) | $ | ( | $ | | $ | ( | $ | | ||||
Net income attributable to Legacy Wentworth Management Services LLC members |
| — |
| | ||||||||
Net loss attributable to Binah Capital Group, Inc. | $ | ( | ( | |||||||||
Net loss per share basic and diluted | $ | ( |
| $ | ( | |||||||
Weighted average shares: basic and diluted |
| |
| |
The accompanying notes are an integral part of these unaudited condensed financial statements.
2
BINAH CAPITAL GROUP, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(Unaudited)
(in thousands except for share and per share amounts)
FOR THE THREE MONTHS AND SIX MONTHS ENDED JUNE 30, 2024
For the Three and Six Months Ended June 30, 2024 | ||||||||||||||||||||||
|
| Redeemable Convertible Preferred Stock |
| Common Stock |
|
|
|
|
| |||||||||||||
| Total | |||||||||||||||||||||
Equity Attributed to | Stockholders’ | |||||||||||||||||||||
Legacy Wentworth | Equity, Mezzanine Equity and | |||||||||||||||||||||
Management Services | Additional Paid- | Accumulated | Members’ | |||||||||||||||||||
LLC | Units | Amount | Units | Amount | in Capital | Deficit | Equity | |||||||||||||||
Balance January 1, 2024 | $ | |
| — | $ | — |
| — | $ | — | $ | — | $ | — | $ | | ||||||
Distributions |
| ( |
| — |
| — |
| — |
| — |
| — |
| — |
| ( | ||||||
Net income prior to transaction |
| |
| — |
| — |
| — |
| — |
| — |
| — |
| | ||||||
Reverse merger and recapitalization of legacy Wentworth Management Services LLC |
| ( |
| — |
| — |
| |
| — |
| |
| ( |
| ( | ||||||
Mezzanine Equity - Shares Issued in connection with PIPE financing |
| — |
| |
| |
| — |
| — |
| — |
| — |
| | ||||||
Net loss attributable to Binah Capital Group, Inc. post transaction |
| — |
| — |
| — |
| — |
| — |
| — |
| ( |
| ( | ||||||
Balance March 31, 2024 | $ | — |
| | $ | |
| | $ | — | $ | | $ | ( | $ | | ||||||
Issuance of redeemable convertible preferred stock | — | | | — | — | — | — | | ||||||||||||||
Dividend - redeemable convertible preferred stock | — | — | — | — | — | ( | — | ( | ||||||||||||||
Issuance of common stock in connection with exercise of warrants | — | — | — | | — | | — | | ||||||||||||||
Net Loss | — | — | — | — | — | — | ( | ( | ||||||||||||||
Balance June 30, 2024 | — | | $ | | | $ | — | $ | | $ | ( | $ | |
The accompanying notes are an integral part of these unaudited condensed financial statements.
3
BINAH CAPITAL GROUP, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(in thousands except for share and per share amounts)
| For the six months ended June 30, | |||||
2024 | 2023 | |||||
Cash Flows From Operating Activities | ||||||
Net income (loss) | $ | ( | $ | | ||
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities: |
|
|
|
| ||
Depreciation and amortization |
| |
| | ||
Amortization of debt issuance costs |
| |
| | ||
Non-cash lease expense |
| |
| | ||
Capitalized interest - promissory notes-affiliates |
| |
| | ||
Capitalized interest - due to members |
| — |
| | ||
Loss on disposal of property and leasehold improvements |
| — |
| | ||
Changes in operating assets and liabilities: |
|
|
|
| ||
Due from clearing broker |
| |
| | ||
Commissions receivable |
| ( |
| | ||
Other receivables |
| |
| ( | ||
Other assets |
| ( |
| ( | ||
Accounts payable and accrued expenses |
| ( |
| ( | ||
Commissions payable |
| ( |
| ( | ||
Operating lease liability |
| ( |
| ( | ||
Net Cash (Used in) Provided By Operating Activities |
| ( |
| | ||
Cash Flows From Investing Activities |
|
|
|
| ||
Purchases of property and equipment |
| ( |
| ( | ||
Net Cash Used In Investing Activities |
| ( |
| ( | ||
Cash Flows From Financing Activities |
|
|
|
| ||
Repayment - notes payable |
| ( |
| ( | ||
Repayment of promissory notes-affiliates |
| ( |
| — | ||
Proceeds from borrowings from members | — | | ||||
Repayment of borrowings from members |
| ( |
| — | ||
Net payment for reverse merger and recapitalization |
| ( |
| — | ||
Proceeds from redeemable convertible preferred stock |
| |
| — | ||
Proceeds from exercise of warrants | | — | ||||
Distribution of capital |
| ( |
| ( | ||
Net Cash Provided By (Used In) Financing Activities |
| |
| ( | ||
Net Change in Cash, Cash Equivalents and Restricted Cash |
| ( |
| ( | ||
Cash, Cash Equivalents and Restricted Cash - Beginning of Period | $ | | $ | | ||
Cash, Cash Equivalents and Restricted Cash - End of Period | $ | | $ | | ||
Cash Paid During the Period for: |
|
|
|
| ||
Interest | $ | | $ | | ||
Income taxes | — | — | ||||
Supplemental Disclosure of Non-Cash Financing Activities | ||||||
During the period ended June 30, 2024, the Company paid an in-kind dividend to the Preferred Stockholder in the amount of $ |
The accompanying notes are an integral part of these unaudited condensed financial statements.
4
BINAH CAPITAL GROUP, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
June 30, 20241
1.DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION
Binah Capital Group, Inc. (“Binah Capital”, “Holdings” or the “Company,” representing the consolidated group.), is a Delaware Corporation, formed on June 27, 2022 that serves as a holding company for its wholly-owned subsidiaries operating in the retail wealth management business.
Binah Capital through its wholly owned subsidiary Wentworth Management Services LLC (“Wentworth”) operates multiple businesses in the financial services industry as follows:
● | PKS Holdings, LLC (“PKSH”) is headquartered in Albany, New York and branch offices throughout the United States of America, and includes the following entities (the “PKSH Entities”): |
o | Purshe Kaplan Sterling Investments, Inc. (“PKSI”), incorporated in the State of New York, is an independent broker-dealer registered with the Securities and Exchange Commission (“SEC”) and is a member of the Financial Industry Regulatory Authority (“FINRA”) and the Securities Investors Protection Corporation (“SIPC”). |
o | PKS Advisory Services, LLC (“PKSA”), a New York limited liability company, is an independent investment advisory firm, registered with the SEC, which provides advisory services to clients. |
o | PKS Financial Services, Inc. (“PKSF”), incorporated in the State of New York, is an insurance entity providing financial services to clients. |
o | Representatives Indemnity Company, Inc. (“Repco”), incorporated in the British Virgin Islands, holds a general business insurance license for the purpose of providing professional liability insurance coverage for affiliated entities. |
● | Cabot Lodge Securities LLC maintains offices in New York, New York and branch offices throughout the United States of America and includes the following entities. |
o | Cabot Lodge Securities, LLC (“CLS”), a Delaware Limited Liability Company, is a broker-dealer registered with the SEC and is a member of FINRA and SIPC. |
o | CL Wealth Management, LLC (“CLWM”), a Virginia Limited Liability Company, is an investment advisory firm, registered with the SEC, which provides advisory services to clients. |
o | Wentworth Financial Partners (“WFP”) (f/k/a CL General Agency), a Delaware Limited Liability Company is an insurance entity providing financial services to clients. |
5
● | Michigan Securities, Inc. (“MSI”) maintains offices in Albany, New York and includes the following entities: |
o | MSI, (d/b/a as Broadstone Securities, Inc., “Broadstone”), incorporated in the State of Michigan, is a financial services firm, and is a broker-dealer registered with the SEC and is a member of FINRA. |
o | Michigan Advisors, Inc., (“MAI”) incorporated in the State of Michigan, was a SEC registered investment advisor. MAI withdrew its registration in September 2021. |
o | Insurance Audit Agency, Inc. (“IAA”), incorporated in the state of Michigan, is an insurance agency. |
● | World Equity Group, Inc. (“WEG”), incorporated in the State of Illinois, is registered as a broker-dealer and investment advisor with the SEC and is a member of FINRA and SIPC. WEG maintains offices in Schaumburg, Illinois and has branch offices throughout the United States of America. |
Basis of Presentation
Reverse Recapitalization
On March 15, 2024 (the “Closing Date”), Binah Capital consummated the transactions contemplated by that certain Agreement and Plan of Merger, dated July 7, 2022 (as amended, the “Merger Agreement” and the consummation of such contemplated transactions, the “Closing”), by and among Kingswood Acquisition Corp, a Delaware corporation (“KWAC”), Binah Capital, Kingswood Merger Sub, Inc., a Delaware corporation (“Kingswood Merger Sub”), Wentworth Merger Sub, LLC, a Delaware limited liability company (“Wentworth Merger Sub”), and Wentworth Management Services LLC, a Delaware limited liability company (“Wentworth”). Binah Capital, Kingswood Merger Sub and Wentworth Merger Sub were newly formed entities that were formed for the sole purpose of entering into and consummating the transaction set forth in the Merger Agreement. Binah Capital was a wholly-owned direct subsidiary of KWAC and both Kingswood Merger Sub and Wentworth Merger Sub were wholly-owned direct subsidiaries of Binah Capital. On the Closing Date, Kingswood Merger Sub merged with and into KWAC, with KWAC continuing as the surviving entity as a wholly-owned subsidiary of Binah Capital and Wentworth Merger Sub merged with and into Wentworth, with Wentworth continuing as the surviving entity as a wholly-owned subsidiary of Binah Capital. Following the Wentworth merger, KWAC acquired, and Binah Capital contributed to KWAC all of the common units of Wentworth directly held by Binah Capital after the Wentworth merger, such that, following the Binah Capital contribution, Wentworth became a wholly-owned subsidiary of KWAC.
Notwithstanding the legal form of the Merger pursuant to the Business Combination Agreement, the Merger is accounted for as a reverse recapitalization. Under this method of accounting, KWAC is expected to be treated as the “acquired” company for financial reporting purposes. Accordingly, for accounting purposes, the consolidated financial statements of Binah Capital will represent a continuation of the consolidated financial statements of Wentworth with the business combination treated as the equivalent of the Wentworth issuing shares for the net assets of KWAC, accompanied by a recapitalization. The net assets of KWAC will be stated at historical cost, with no goodwill or other intangible assets recorded. Operations prior to the business combination will be those of Wentworth in future reports of Holdings (See Note 3 – Mergers and Recapitalization).
Basis of Presentation
These unaudited condensed consolidated financial statements (“condensed consolidated financial statements”) are prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”), which requires the Company to make estimates and assumptions regarding the valuation and impairments of intangible assets and deferred income taxes, allowance for credit losses, contingencies, and other matters that affect the condensed consolidated financial statements and related disclosures. The condensed consolidated financial statements reflect all adjustments which are in the opinion of management, necessary to represent fairly the results of operations for the interim periods presented. Actual results could differ from those estimates under different assumptions and the differences may be material to the condensed financial statements.
6
1. | DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (continued) |
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of Holdings and its wholly owned subsidiaries. Significant inter-company transactions and balances were eliminated in consolidation.
2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Use of Estimates and Assumptions
The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the valuation and impairments of intangible assets and deferred income taxes, allowance for credit losses, and contingencies.
Revenue Recognition
Revenues from contracts with customers are recognized when control of the promised services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. For additional information see Note 4 - Revenues From Contracts with Customers.
Cash, Cash Equivalents and Restricted Cash
Cash and cash equivalents consist primarily of cash on deposit and money market funds all of which have original maturities of three months or less.
Restricted cash represents cash held by the Company’s lender related to its credit facility. As of June 30, 2024 and December 31, 2023 restricted cash amounted to approximately $
The Company regularly maintains cash, cash equivalents and restricted cash that exceed Federal Deposit Insurance Corporation limits. The Company has not experienced any losses and does not believe it is exposed to any significant credit risk from cash.
Receivables
Receivables, which amounted to approximately $
Financial Instruments – Credit Losses. The Company accounts for estimated credit losses on financial assets measured at an amortized cost basis and certain off-balance sheet credit exposures in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 326-20, Financial Instruments-Credit Losses. FASB ASC 326-20 requires the Company to estimate expected credit losses over the life of its financial assets and certain off-balance sheet exposures as of the reporting date based on relevant information about past events, current conditions, and reasonable and supportable forecasts. The Company records the estimate of expected credit losses as an allowance for credit losses. For financial assets measured at an amortized cost basis the allowance for credit losses is reported as a valuation account on the statement of financial condition that adjusts the asset’s amortized cost basis. Changes in the allowance for credit losses are reported in credit loss expense, if applicable. Management believes its risk of loss on currently recorded receivables is minimal and accordingly an allowance for credit losses has been recorded as of June 30, 2024, and December 31, 2023, and January 1, 2023 in the amount of $
7
2. | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued) |
Goodwill and Other Intangible Assets
Goodwill is tested annually for impairment or if certain events occur indicating that the carrying amounts may be impaired. If a qualitative assessment is used and the Company determines that the fair value of a reporting unit is more likely than not (i.e., a likelihood of more than 50%) less than its carrying amount, a quantitative impairment test will be performed. An impairment loss will be recognized if a reporting unit’s carrying amount exceeds its fair value, to the extent that it does not exceed the total carrying amount of goodwill.
Intangible assets that are deemed to have definite lives are amortized over their useful lives, generally ranging from
There was
Income Taxes
For the periods prior to the Reverse Merger and Recapitalization, Wentworth was treated as a partnership for income tax purposes and therefore not subject to federal taxes. Wentworth was subject to certain state and local income taxes. Additionally, KWAC was treated as a corporation and subject to U.S. federal income taxes, in addition to state and local income taxes.
Subsequent to the Reverse Merger and Recapitalization, KWAC, a wholly-owned subsidiary of Holdings, is the parent company of Wentworth, which is treated as a partnership for federal income tax purposes. As a partnership, Wentworth is itself generally not subject to U.S. federal income tax under current U.S. tax laws, and any taxable income or loss is passed through and included in the taxable income or loss of its members, including KWAC. KWAC is subject to U.S. federal income taxes, in addition to state and local income taxes, with respect to its distributive share of the items of the net taxable income or loss and any related tax credits of Wentworth. Additionally, Binah Capital Group, Inc., a corporation, is subject to U.S. federal income taxes, in addition to state and local income taxes.
KWAC, the PKSH Entities, Cabot Entities and WEG are taxable entities subject to federal, state, and local income taxes. Therefore, these consolidated financial statements include an income tax provision for the taxable entities only. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amount of existing assets and liabilities and their respective tax bases and net operating loss carryforwards.
Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company periodically evaluates deferred tax assets and net operating loss carryforwards to determine their recoverability based primarily on the Company’s ability to generate future taxable income. A valuation allowance may be established to reduce deferred tax assets, if it is more likely than not that all, or some portion, of such deferred tax assets will not be realized.
The Company accounts for taxes in accordance with the asset and liability method of accounting for income taxes. Under this method, the Company must recognize the tax benefit from an uncertain tax position only if it is “more likely than not” that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution.
8
2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Net Loss Per Share
Basic earnings per share of common stock is computed by dividing net income attributable to the Company by the weighted-average number of shares of Class A common stock outstanding during the same period. Diluted net income per share of common stock is computed by dividing net income attributable to the Company by the weighted-average number of shares of common stock outstanding adjusted to give effect to potentially dilutive securities. Potential shares of common stock consist of incremental shares issuable upon the assumed exercise of stock options and warrants and conversion of the Company’s preferred stock. Net income (loss) per share is not presented for periods prior to the Merger as such amounts would not be meaningful to users of the financial statements because the equity structure materially changed in connection with the Merger.
Financial Instruments
The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risks. The Company does not hold or issue financial instruments for speculative or trading purposes.
As a result of the Reverse Recapitalization, the Company has issued and has outstanding warrants. The Company evaluates the warrants, to determine if such instruments should be considered stock-based compensation, pursuant to ASC Topic 718, and if not in the scope of ASC 718, if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC Topic 480 and ASC Topic 815. The determination of whether the instrument should be classified as stock-based compensation or a derivative instrument, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
Warrants issued to non-employees (the “Non-employee Warrants”) were not classified as stock-based compensation as there is no condition of employment such that the granting of the shares does not represent compensation. The Non-employee Warrants are classified as derivative liabilities under ASC Topic 480 or ASC Topic 815. Public Warrants to non-employees are measured at fair value on recurring basis, using the market approach based upon the quoted market price of Binah Capital Group, Inc.’s Public Warrants at the end of each reporting period. Private Placement Warrants issued to non-employees are measured at fair value on a recurring basis based upon the quoted price for similar liabilities (Public Warrants issued to non-employees) in active markets as of the end of each period.
Contingent Liabilities
The Company recognizes liabilities for contingencies when there is an exposure that, when fully analyzed, indicates potential losses become probable and can be reasonably estimated. Whether a potential loss is probable and can be reasonably estimated is based on currently available information and is subject to significant judgment, a variety of assumptions and uncertainties.
When a potential loss is probable and the loss or range of loss can be estimated, the Company will accrue the most likely amount within that range. No liability is recognized for those matters which, in management’s judgment, the determination of a reasonable estimate of potential loss is not possible, or for which a potential loss is not determined to be probable.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as modified by the Jumpstart Our Business Startups Act of 2012, and it thus may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies.
9
2.SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
Recently Issued Accounting Pronouncements
In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures to enhance the transparency of income tax disclosures relating to the rate reconciliation, disclosure of income taxes paid, and certain other disclosures. The ASU should be applied prospectively and is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact on the related disclosures; however, it does not expect this update to have an impact on its financial condition or results of operations.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures to improve the disclosures about reportable segments and include more detailed information about a reportable segment’s expenses. This ASU also requires that a public entity with a single reportable segment, like the Company, provide all of the disclosures required as part of the amendments and all existing disclosures required by Topic 280. The ASU should be applied retrospectively to all prior periods presented in the consolidated financial statements and is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact on the related disclosures; however, it does not expect this update to have an impact on its financial condition or results of operations.
Recently Adopted Accounting Pronouncements
There were no new accounting pronouncements during the three months ended June 30, 2024 that materially impacted the Company’s condensed consolidated financial statements and related disclosures.
3.MERGER AND RECAPITALIZATION
Upon the consummation of the Business Combination, (i) the holders of shares of KWAC’s common stock (“KWAC Common Stock”) issued and outstanding immediately prior to the effective time of the Business Combination (other than any redeemed shares) received
Additionally, on the Closing Date, Holdings entered into a Subscription Agreement with an investor for the purchase of
10
3.MERGER AND RECAPITALIZATION (continued)
Holdings applied to have the Holdings Common Stock and Holdings Warrants listed on the Nasdaq Global Market (the “Nasdaq”) under the symbols BCG and BCG.W, respectively. Prior to the mergers, the KWAC Class A Common Stock and KWAC Public Warrants were listed on the OTC Exchange under the symbols “KWAC” and “KWAC.WS,” respectively.
On March 26, 2024, Holdings received approval for Holding’s securities to be listed on the Nasdaq Stock Market LLC. Holdings common stock is listed on the Nasdaq Global Market and its warrants will be listed on the Nasdaq Capital Market under the symbols “BCG” and “BCG.W”, respectively.
4.REVENUES FROM CONTRACTS WITH CUSTOMERS
Revenues from contracts with customers are recognized when control of the promised services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Revenues are analyzed to determine whether the Company is the principal (i.e., reports revenues on a gross basis) or agent (i.e., reports revenues on a net basis) in the contract. Principal or agent designations depend primarily on the control an entity has over the product or service before control is transferred to a customer. The indicators of which party exercises control include primary responsibility over performance obligations before the good or service is transferred and discretion in establishing the price.
Commissions
Commission revenues represent sales commissions generated by advisors for their clients’ purchases and sales of securities on exchanges and over-the-counter, as well as purchases of other investment products. The Company views the selling, distribution and marketing, or any combination thereof, of investment products to such clients as a single performance obligation to the product sponsors.
The Company is the principal for commission revenues, as it is responsible for the execution of the clients’ purchases and sales and maintains relationships with the product sponsors. Advisors assist the Company in performing its obligations. Accordingly, total commission revenues are reported on a gross basis.
The Company generates two types of commission revenues: sales-based commissions that are recognized at the point of sale on the trade date and trailing commissions that are recognized over time as earned. Sales-based commission revenues vary by investment product and are based on a percentage of an investment product’s current market value at the time of purchase. Trailing commission revenues are generally based on a percentage of the current market value of clients’ investment holdings in trail-eligible assets, and are recognized over the period during which services, such as ongoing support, are performed. As trailing commission revenues are based on the market value of clients’ investment holdings, the consideration is variable, and an estimate of the variable consideration is constrained due to dependence on unpredictable market impacts. The constraint is removed once the investment holdings value can be determined.
Advisory Fees
Advisory fees represent fees charged to advisors’ clients’ accounts on the Company’s corporate advisory platform. The Company provides ongoing investment advice, brokerage and execution services on transactions, and performs administrative services for these accounts. This series of performance obligations transfers control of the services to the client over time as the services are performed. These revenues are recognized ratably over time to match the continued delivery of the performance obligations to the client over the life of the contract. The advisory revenues generated from the Company’s corporate advisory platform are based on a percentage of the market value of the eligible assets in the clients’ advisory accounts. As such, the consideration for these revenues is variable and an estimate of the variable consideration is constrained due to dependence on unpredictable market impacts on client portfolio values. The constraint is removed once the portfolio value can be determined.
The Company provides advisory services to clients on its corporate advisory platform through the advisor. The Company is the principal in these arrangements and recognizes advisory revenues on a gross basis, as the Company is responsible for satisfying the performance obligations and has control over determining the fees.
11
4.REVENUES FROM CONTRACTS WITH CUSTOMERS (continued)
The following table presents total revenue from contracts with customers disaggregated by investment product for the periods ended June 30 (in thousands):
Three Months Ended | Six Months Ended | |||||||||||
June 30, | June 30, | |||||||||||
Revenue From Contracts With Customers |
| 2024 |
| 2023 |
| 2024 |
| 2023 | ||||
Variable annuities and other insurance commissions | $ | | $ | | $ | | $ | | ||||
Mutual fund commissions |
| |
| |
| |
| | ||||
Securities commissions |
| |
| |
| |
| | ||||
Alternative investments |
| |
| |
| |
| | ||||
Advisory fees |
| |
| |
| |
| | ||||
Total Revenue From Contracts With Customers | $ | | $ | | $ | | $ | |
The following tables presents sales-based and trailing revenues disaggregated by product category for the periods ended June 30 (in thousands):
Three Months Ended | Six Months Ended | |||||||||||
June 30, | June 30, | |||||||||||
Sales-based (Point in time) |
| 2024 |
| 2023 |
| 2024 |
| 2023 | ||||
Variable annuities and other insurance commissions | $ | | $ | | $ | | $ | | ||||
Mutual fund commissions |
| |
| |
| |
| | ||||
Securities commissions |
| |
| |
| |
| | ||||
Alternative investments |
| |
| |
| |
| | ||||
Total Sales Based Revenues | $ | | $ | | $ | | $ | |
Three Months Ended | Six Months Ended | |||||||||||
June 30, | June 30, | |||||||||||
Trailing (Over time) |
| 2024 |
| 2023 |
| 2024 |
| 2023 | ||||
Variable annuities and other insurance commissions | $ | | $ | | $ | | $ | | ||||
Mutual fund commissions |
| |
| |
| |
| | ||||
Advisory fees |
| |
| |
| |
| | ||||
Alternative investments |
| |
| |
| |
| | ||||
Total Trailing Revenues |
| |
| |
| |
| | ||||
Total Revenue From Contracts With Customers | $ | | $ | | $ | | $ | |
Contract Balances
The timing of revenue recognition may differ from the timing of payment by the Company’s customers. The Company records a receivable when revenue is recognized prior to payment and there is an unconditional right to payment. The Company records a contract asset when the Company has recognized revenue prior to payment but the Company’s right to payment is conditional on something other than the passage of time. Alternatively, when payment precedes the provision of the related services, the Company records deferred revenues (a contract liability) until the performance obligations are satisfied. As of June 30, 2024, and December 31, 2023, the Company had receivables from contracts with customers totaling approximately $
Interest and Other Income
The Company earns interest income from client margin accounts and cash equivalents This revenue is not generated from contracts with customers. Additionally, the Company receives marketing fees and sponsorship income.
12
5.FAIR VALUE
The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes the following hierarchy used in fair value measurements and expands the required disclosures of assets and liabilities measured at fair value:
● | Level 1 - Inputs use quoted unadjusted prices in active markets for identical assets or liabilities that the Company can access. |
● | Level 2 - Fair value measurements use other inputs that are observable, either directly or indirectly. These inputs include quoted prices for similar assets and liabilities in active markets as well as other inputs such as interest rates and yield curves that are observable at commonly quoted intervals. |
● | Level 3 - Inputs that are unobservable inputs, including inputs that are available in situations where there is little, if any, market activity for the related asset or liability. The inputs or methodology used for valuing assets and liabilities are not necessarily an indication of the risk associated with investing in those assets and liabilities. |
Certain financial instruments are carried at cost on the statement of financial condition, which approximates fair value due to their short-term, highly liquid nature. The carrying value of debt approximates their fair value since the interest rates on these obligations represent current market rates.
6.DEBT
On April 2, 2020, the Company entered into a Credit Agreement (the “Credit Agreement”) with Oak Street Funding LLC (“Oak Street”) in the amount of $
On April 25, 2021, the Company entered into an additional promissory note with Oak Street in the amount of $
Under the Oak Street notes, the Company is subject to certain covenants as defined in the agreements. As of June 30, 2024 and December 31, 2023, the Company was in compliance with all financial related covenants.
The minimum payments and maturities of the Oak Street notes as of June 30, 2024, are as follows (in thousands):
2024 |
| $ | |
2025 |
| | |
2026 |
| | |
2027 |
| | |
2028 |
| | |
Thereafter |
| | |
Total | $ | |
In connection with the closing of the Business Combination, the Company entered into an amendment to the Credit Agreement with Oak Street providing for, among other things, consenting to the Business Combination, and the payoff and restructuring of certain debt obligations. Additionally, the rate of interest being charged will increase at rate of
13
6.DEBT (continued)
The amended Credit Agreement also includes a guarantee provision whereby each of the Company, KWAC, Holdings and MHC Securities, LLC are guarantors under the Credit Agreement. Additionally, certain of the members of the Company provide guarantees under the Credit Agreement.
7.PROMISSORY NOTES – AFFILIATES
On November 30, 2017, Wentworth issued subordinated promissory notes in the aggregate principal amount of approximately $
Additionally, in connection with the acquisition of the PKSH Entities, Wentworth agreed to pay contingent consideration in the amount of $
As of December 31, 2023, the amount of principal and accrued interest related to these promissory notes was approximately $
In connection with the closing of the Business Combination, the Company paid approximately $
8.DUE TO MEMBERS
Wentworth had entered into promissory notes with certain of its members to provide for working capital. As of December 31, 2023, the amount of principal and accrued interest related to these notes were approximately $
In connection with the closing of the Business Combination, the noteholders agreed to satisfy all outstanding obligations, including the payment of principal and interest, in exchange for an amount of cash equal to approximately $
9.REDEEMABLE CONVERTIBLE PREFERRED STOCK
On March 15, 2024 (the “Funding Date”), in connection with the consummation of the Business Combination, Holdings and Wentworth entered into a Subscription Agreement with an investor for the purchase of
Additionally, the Holdings Series A Stock carries a cumulative dividend at a rate of nine percent (
14
9.REDEEMABLE CONVERTIBLE PREFERRED STOCK (continued)
The Holdings Series A Stock has liquidation preferences in the event of a voluntary or involuntary liquidation as follows:
● | The greater of $ |
● | $ |
● | $ |
● | $ |
Holdings, at its option, may redeem the Series A Stock on any anniversary of the Funding date up to an including the fourth anniversary of the Funding date at the following redemption prices:
● | $ |
● | $ |
● | $ |
● | $ |
If the Series A Stock have not previously been redeemed or converted, the Series A Stock will be redeemed by Holdings on the fourth anniversary of the Funding Date.
10.WARRANTS
The following table summarizes the warrants outstanding as of June 30, 2024:
Class of Warrants |
| Number Outstanding |
Public warrants |
| |
Private placement warrants |
| |
Total warrants outstanding |
| |
Each whole Warrant entitles the registered holder to purchase
Except as described in this section, the Private Warrants have terms and provisions that are identical to those of the Public Warrants, except the Private Warrants are not subject to redemption, and do not become subject to redemption after transfer to a non-affiliate (a distinction from other private placement warrants issued in connection with SPAC transactions).
The Warrants are classified as derivative liabilities under ASC Topic 480 or ASC Topic 815. At
15
11.INCOME TAXES
As a result of the Reverse Recapitalization, Binah Capital Group, Inc. is the parent company of KWAC, which is the parent company of Wentworth. KWAC is a corporation and subject to U.S. federal and certain state and local taxes. Wentworth is treated as a partnership for U.S. federal income tax purposes.
KWAC, the PKSH Entities, Cabot Entities and WEG are taxable entities and are subject to federal, state, and local income taxes. Therefore, these consolidated financial statements include an income tax provision for the taxable entities only.
The effective tax rate was approximately (
The Company files income tax returns, including returns for its subsidiaries, with federal and state jurisdictions. The Company is generally not subject to examinations for its federal and state returns for any periods prior to the 2019 tax year. The Company is not currently under examination for any tax years.
12.NET LOSS PER SHARE
The Series A Preferred Stock does not have similar economic rights to the common stock and management does not consider them to be in substance common shares for earnings per share (“EPS”) purposes. As a result, the weighted average Series A Preferred Stock outstanding during the period was not included in the calculation of weighted average common stock outstanding. The Public and Private Warrants were considered in diluted EPS under the treasury stock method, if dilutive.
Management determined that EPS was not presented for periods prior to the Merger as it was not considered to be meaningful.
The computation of loss per share and weighted average of the Company’s common stock outstanding for the period from the date of transaction close through June 30, 2024 is as follows (in thousands):
Three months | Six Months | ||||
ended June 30, | Ended June 30, | ||||
| 2024 |
| 2024 | ||
Net (loss) |
| $ | |||
Basic and diluted weighted average shares outstanding, common stock |
| | | ||
Basic and diluted loss per share of common stock | $ | ( | ( |
The following table details the securities that have been excluded from the calculation of weighted-average shares for diluted earnings per share for the period presented as they were anti-dilutive (in thousands).
Warrants |
| |
16
13.COMMITMENTS AND CONTINGENCIES
Litigation
Certain conditions may exist as of the date the consolidated financial statements are issued which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company, or unasserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or unasserted claims, as well as the perceived merits of the amount of relief sought or expected to be sought therein.
If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the accompanying consolidated financial statements. If the assessment indicates that a potentially material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability and an estimate of the range of possible losses, if determinable and material, would be disclosed. Loss contingencies considered remote are generally not disclosed, unless they involve guarantees, in which case the guarantees would be disclosed.
There can be no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.
The Company is a defendant or respondent in various pending and threatened arbitrations, administrative proceedings and lawsuits seeking compensatory damages. Claim amounts are infrequently indicative of the actual amounts the Company will be liable for, if any. Many of these claimants also seek, in addition to compensatory damages, punitive or treble damages, and all seek interest, costs and fees. These matters arise in the normal course of business. The Company intends to vigorously defend itself in these actions, and the ultimate outcome of these matters cannot be determined at this time.
In many lawsuits, arbitrations, and regulatory proceedings, it is not possible to determine whether a liability has been incurred or to estimate the amount of that liability until the matter is close to resolution. However, accruals are reviewed regularly and are adjusted to reflect management’s estimates of the impact of developments, rulings, advice of counsel and any other information pertinent to a particular matter.
Because of the inherent difficulty in predicting the ultimate outcome of legal and regulatory actions, management cannot predict with certainty the eventual loss or range of loss related to such matters. The Company believes, based upon current information, that the outcome of any such legal proceeding, claim, dispute, or investigation will not have a material effect on the Company’s financial position, results of operations or cash flows. However, the actual outcomes of such legal proceedings, claims, disputes, or investigations could be material to the Company’s operating results and cash flows for a particular future period as additional information is obtained.
Indemnification
The activities of the Company’s customers are transacted on either a cash or margin basis through the facilities of its clearing broker. In margin transactions, the clearing broker extends credit to the customers, subject to various regulatory and margin requirements, collateralized by cash and securities in the customer’s account. In connection with these activities, the clearing broker may also execute and clear customer transactions involving the sale of securities not yet purchased.
These transactions may expose the Company to significant off-balance sheet risk in the event margin requirements are not sufficient to fully cover losses which the customers may incur. In the event the customers fail to satisfy their obligations to the clearing broker, the Company may be required to compensate the clearing broker for losses incurred on behalf of the customers.
The Company, through its clearing broker, seeks to control the risk associated with its customers’ activities by requiring customers to maintain margin collateral in compliance with various regulatory and internal guidelines.
As of June 30, 2024, and December 31, 2023, management of the Company had not been notified by any clearing brokers, nor were they otherwise aware of any potential losses relating to this indemnification.
17
14.COMMON STOCK, PREFERRED STOCK AND STOCKHOLDERS’ EQUITY
The Company is authorized to issue
● |
● |
15.NET CAPITAL REQUIREMENTS
The Company operates four registered broker-dealers that are subject to the SEC Uniform Net Capital Rule (Rule 15c3-1). This requires the Company to maintain certain minimum net capital requirements. As of and for the periods ended June 30, 2024 and December 31, 2023, all broker-dealers had net capital in excess of the required minimums.
16.CREDIT RISK AND CONCENTRATIONS
Financial instruments that subject the Company to credit risk consist principally of receivables and cash and cash equivalents. The Company performs certain credit evaluation procedures and does not require collateral for financial instruments subject to credit risk. The Company believes that credit risk is limited because the Company routinely assesses the financial strength of its counterparties and, based upon factors surrounding the credit risk of its counterparties, establishes an allowance for uncollectible accounts and, consequently, believes that its receivables credit risk exposure beyond such allowances is limited.
17.SUBSEQUENT EVENTS
The Company evaluated subsequent events that occurred after the balance sheet date up to August 14, 2024.
18
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this report. References to the “Company,” “us” or “we” refer to Binah Capital Group, Inc.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other Securities and Exchange Commission (“SEC”) filings.
Business Overview
Binah Capital Group, Inc., a Delaware corporation (the “Company), is a leading consolidator of retail wealth management businesses that owns and operates ten entities, four of which are broker-dealers, three of which are registered investment advisors, and three of which are insurance entities, that have over 1900 registered individuals working within the financial services industries.
The Company focuses on three critical areas comprised of the hybrid, independent and W2 business models to allow affiliated advisors to choose the operating model that works best for them and run their practices on their own terms. The Company’s platform adds to its flexibility by providing a variety of custody and clearing firm options to accommodate the unique business needs of advisors.
The Merger
On March 15, 2024 (the “Closing Date”), Binah Capital consummated the transactions contemplated by that certain Agreement and Plan of Merger, dated July 7, 2022 (as amended, the “Merger Agreement” and the consummation of such contemplated transactions, the “Closing”), by and among Kingswood Acquisition Corp, a Delaware corporation (“KWAC”), Binah Capital, Kingswood Merger Sub, Inc., a Delaware corporation (“Kingswood Merger Sub”), Wentworth Merger Sub, LLC, a Delaware limited liability company (“Wentworth Merger Sub”), and Wentworth Management Services LLC, a Delaware limited liability company (“Wentworth”). Binah Capital, Kingswood Merger Sub and Wentworth Merger Sub were newly formed entities that were formed for the sole purpose of entering into and consummating the transaction set forth in the Merger Agreement. Binah Capital was a wholly-owned direct subsidiary of KWAC and both Kingswood Merger Sub and Wentworth Merger Sub were wholly-owned direct subsidiaries of Binah Capital. On the Closing Date, Kingswood Merger Sub merged with and into KWAC, with KWAC continuing as the surviving entity as a wholly-owned subsidiary of Binah Capital and Wentworth Merger Sub merged with and into Wentworth, with Wentworth continuing as the surviving entity as a wholly-owned subsidiary of Binah Capital. Following the Wentworth merger, KWAC acquired, and Binah Capital contributed to KWAC all of the common units of Wentworth directly held by Binah Capital after the Wentworth merger, such that, following the Binah Capital contribution, Wentworth became a wholly-owned subsidiary of KWAC.
19
Upon the consummation of the Business Combination, (i) the holders of shares of KWAC’s common stock (“KWAC Common Stock”) issued and outstanding immediately prior to the effective time of the Business Combination (other than any redeemed shares) received one share of common stock of Holdings (“Holdings Common Stock”) in exchange for each share of KWAC Common Stock held by them, subject to adjustment as more fully described herein, (ii) 1,100,000 shares of Holdings Common Stock issued to Sponsor was placed by Holdings into an escrow account and will not be released to the Sponsor unless the dollar volume-weighted average price of Holdings Common Stock exceeds $12.00 for 20 trading days within any 30-day trading period during the four-year period following the consummation of the Business Combination, (iii) the holders of each whole warrant to purchase KWAC Class A Common Stock received one warrant to purchase Holdings Common Stock at an exercise price of $11.50 per share, (iv) 12 million shares of Holdings Common Stock, subject to adjustment as more fully described herein, was issued to the equity holders of Wentworth in proportion to their ownership interests in Wentworth, (v) an additional 1,100,000 shares of Holdings Common Stock was issued to certain equity holders of Wentworth, (vi) 3,084,450 KWAC Private Placement Warrants held by Sponsor were forfeited immediately prior to the effective time of the Business Combination, and (vii) 3,084,450 warrants to purchase Holding Common Stock at an exercise price of $11.50 per share were issued to the equity holders of Wentworth in proportion to their ownership interests in Wentworth. As a result of the Business Combination, Wentworth became an indirect, wholly-owned subsidiary of Holdings.
Additionally, on the Closing Date, Holdings entered into a Subscription Agreement with an investor for the purchase of 1,500,000 shares of Holdings’ Series A Redeemable Convertible Preferred Stock (the “Holdings Series A Stock”) in a private placement at $9.60 per share, for an aggregate purchase price of $14,400,000 (the “Series A PIPE”). The Holdings Series A Stock may be converted into shares of Holdings Common Stock after the second anniversary of the closing of the Series A PIPE, which such conversion shall initially be 1.5 shares of Holdings Common Stock for each share of Series A Convertible Preferred Stock, subject to certain adjustments provided in the Certificate of Designations.
Our Sources of Revenue
Our revenue is derived primarily from fees and commissions from products and advisory services offered by our advisors to their clients, a substantial portion of which we pay out to our advisors.
Executive Summary
Financial Highlights
Results for the three and six-month period ended June 30, 2024 included a net loss of approximately $(0.7) million and $(2.3) million and total revenue of approximately $40.6 million and $82.1 million, respectively, which compares to net income and total revenue of $0.1 million and $1.2 million and approximately $40.4 million and $83.8 million, respectively, for the three and six month period ended June 30, 2023.
Asset Trends
Total advisory and brokerage assets served were $25.1 billion at June 30, 2024, compared to $23.1 billion at June 30, 2023. Total net new assets were $(0.8) billion and $(2.2) billion for the three and six-month period ended June 30, 2024, compared to $(1.0) billion and $(2.1) billion for the same period in 2023.
Net new advisory assets were $0.0 billion and $(0.1) billion for the three and six-month period ended June 30, 2024, compared to $(0.3) billion and $(0.4) billion for the same period in 2023. Advisory assets were $2.3 billion at June 30, 2024, which is approximately a 13% increase from the $2.0 billion at June 30, 2023.
Net new brokerage assets were $(0.8) billion and $(2.1) billion for the three and six-month period ended June 30, 2024, compared to $(0.7) billion and $(1.7) billion for the same period in 2023. Brokerage assets were $22.8 billion at June 30, 2024, up approximately 8% from $21.1 billion at June 30, 2023.
Gross Profit Trend
Gross profit, a non-GAAP financial measure, was $7.3 million and $15.1 million for the three and six-month period ended June 30, 2024, a decrease of 3% from $7.5 million for the three months ended June 30, 2023 and a decrease of 5% from $15.8 million for the six months ended June 30, 2023. See the “Key Performance Metrics and Non-GAAP Financial Measures” section for additional information on gross profit.
20
Key Performance Metrics and Non-GAAP Financial Measures
We focus on several key metrics in evaluating the success of our business relationships and our resulting financial position and operating performance. Our key metrics of Gross Profit and EBITDA are “non-GAAP financial measures.” Our management periodically uses certain “non-GAAP financial measures,” as such term is defined under the rules of the SEC, to supplement our financial information presented in accordance with GAAP and to clarify and enhance understanding of past performance and prospects for the future. Generally, a non-GAAP financial measure is a numerical measure of a company’s operating performance, financial position or cash flows that excludes or includes amounts that are included in or excluded from the most directly comparable measure calculated and presented in accordance with GAAP. Management believes that the non-GAAP financial measures of Gross Profit and EBITDA provide investors and analysts useful insight into our financial position and operating performance. Any non-GAAP measure provided should be viewed in addition to, and not as an alternative to, the most directly comparable measure determined in accordance with U.S. GAAP. Further, the calculation of these non-GAAP financial measures may differ from the calculation of similarly titled financial measures presented by other companies and therefore may not be comparable among companies.
Gross profit is defined as total revenue less commissions paid to financial advisors and registered representatives and other fees that generate the revenue. We consider our gross profit amounts to be non-GAAP financial measures that may not be comparable to those of others in our industry. We believe that gross profit amounts can provide investors with useful insight into our core operating performance before other costs that are general and administrative in nature.
EBITDA is a non-GAAP financial measure defined as net income plus interest expense, provision for income taxes, and depreciation and amortization. The Company presents EBITDA because management believes that it can be a useful financial metric in understanding the Company’s earnings from operations. EBITDA is not a measure of the Company’s financial performance under GAAP and should not be considered as an alternative to net income or any other performance measure derived in accordance with GAAP.
A reconciliation of our non-GAAP financial measures to their most directly comparable GAAP financial measures appears below in the footnotes to the table of our key operating, business and financial metrics.
Our key operating, business and financial metrics are as follows:
As of and for the Periods Ended June 30, | ||||||
Operating Metric (dollars in billions) |
| 2024 |
| 2023 | ||
Advisory and Brokerage Assets |
|
|
|
| ||
Brokerage assets | $ | 22.8 | $ | 21.1 | ||
Advisory assets |
| 2.3 |
| 2.0 | ||
Total Advisory and Brokerage Assets | $ | 25.1 | $ | 23.1 |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||
Net New Assets |
| 2024 |
| 2023 |
| 2024 |
| 2023 | ||||
Net new brokerage assets | $ | (0.8) | $ | (0.7) | $ | (2.1) | $ | (1.7) | ||||
Net new advisory assets |
| (0.0) |
| (0.3) |
| (0.1) |
| (0.4) | ||||
Total Net New Assets | $ | (0.8) | $ | (1.0) | $ | (2.2) | $ | (2.1) |
| For the three months ended |
| For the six months ended | |||||||||
June 30, | June 30, | |||||||||||
Financial Metrics (dollars in millions) |
| 2024 |
| 2023 |
| 2024 |
| 2023 | ||||
Total revenue | $ | 40.6 | $ | 40.4 | $ | 82.1 | $ | 83.8 | ||||
Net income | $ | (0.7) | $ | 0.1 | $ | (2.3) | $ | 1.2 | ||||
Non-GAAP Financial Metrics (dollars in millions) |
|
|
|
|
|
|
|
| ||||
Gross Profit(1) | $ | 7.3 | $ | 7.5 | $ | 15.1 | $ | 15.8 | ||||
EBITDA(2) | $ | 0.6 | $ | 2.2 | $ | 0.5 | $ | 5.0 |
(1) | Gross profit is a non-GAAP financial measure defined as total revenue less commissions paid to financial advisors and registered representatives and other fees that generate the revenue. We consider our gross profit amounts to be non-GAAP financial measures that may not be comparable to those of others in our industry. We believe that gross profit amounts can provide investors with useful insight into our core operating performance before other costs that are general and administrative in nature. Below is a calculation of gross profit for the periods presented (in millions): |
21
For the three months ended June 30, | For the six months ended June 30, | |||||||||||
Gross Profit |
| 2024 |
| 2023 |
| 2024 |
| 2023 | ||||
Total revenue | $ | 40.6 | $ | 40.4 | $ | 82.1 | $ | 83.8 | ||||
Commission and fees |
| 33.4 |
| 32.9 |
| 67.0 |
| 68.0 | ||||
Gross Profit | $ | 7.3 | $ | 7.5 | $ | 15.1 | $ | 15.8 |
(2) | EBITDA is a non-GAAP financial measure defined as net income plus interest expense, provision for income taxes, and depreciation and amortization. The Company presents EBITDA because management believes that it can be a useful financial metric in understanding the Company’s earnings from operations. EBITDA is not a measure of the Company’s financial performance under GAAP and should not be considered as an alternative to net income or any other performance measure derived in accordance with GAAP. Below is a reconciliation of net income to EBITDA for the periods presented (in millions): |
For the three months ended June 30, | For the six months ended June 30, | |||||||||||
EBITDA Reconciliation |
| 2024 |
| 2023 |
| 2024 |
| 2023 | ||||
Net income | $ | (0.7) | $ | 0.1 | $ | (2.3) | $ | 1.2 | ||||
Interest expense |
| 0.8 |
| 1.5 |
| 1.9 |
| 2.6 | ||||
Provision for income taxes |
| 0.1 |
| 0.2 |
| 0.3 |
| 0.5 | ||||
Depreciation and amortization |
| 0.3 |
| 0.3 |
| 0.6 |
| 0.6 | ||||
EBITDA | $ | 0.6 | $ | 2.2 | $ | 0.5 | $ | 5.0 |
Economic Overview and Impact of Financial Market Events
Our business is directly and indirectly sensitive to several macroeconomic factors and the state of the United States financial markets.
According to the most recent estimate from the U.S. Bureau of Economic Analysis, the U.S. economy grew at an annualized pace of 2.8% in the second quarter of 2024, after growing at an annualized pace of 1.6% in the first quarter of this year. Although inflation, rising interest rates and volatile global markets were all headwinds the U.S. economy added roughly 503,000 jobs in the second quarter of 2024, while the unemployment rate averaged 4.0% in the second quarter of 2024, up slightly from the average in the prior quarter.
Our business is also sensitive to current and expected short-term interest rates, which are largely driven by Fed policy. During the second quarter of 2024, Fed policymakers maintained the target range for the federal funds rate from 5.25% to 5.50%. The equity markets rebounded resulting in the S&P 500 returning 4.3% during the second quarter of 2024.
Please consult the Factors Affecting Our Financial Condition and Results of Operations, including those described in the section titled “Risk Factors.”
Basis of Presentation
Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Currently, we conduct business through one operating segment. The consolidated financial statements have been prepared assuming that we will continue as a going concern. See Note 1 in the accompanying consolidated financial statements for further details.
22
Results of Operations
The following presents an analysis of our results of operations for the three and six-month periods ended June 30, 2024 and 2023 (in thousands):
For the three months ended June 30, | For the six months ended June 30, |
| |||||||||||
| 2024 | 2023 | % Change | 2024 |
| 2023 |
| % Change |
| ||||
Revenues: |
|
|
|
|
|
|
|
|
| ||||
Revenue from Contracts with Customers: |
|
|
|
|
|
|
|
|
| ||||
Commissions |
| 33,663 | 33,323 | 1.0 | % | 68,057 |
| 68,643 |
| -0.9 | % | ||
Advisory Fees |
| 6,320 | 5,259 | 20.2 | % | 12,004 |
| 10,886 |
| 10.3 | % | ||
Total Revenue from Contracts with Customers |
| 39,983 | 38,582 | 3.6 | % | 80,061 |
| 79,529 |
| ||||
Interest and other income |
| 665 | 1,857 | -64.2 | % | 2,034 |
| 4,294 |
| -52.6 | % | ||
Total revenues |
| 40,648 | 40,439 | 0.5 | % | 82,095 |
| 83,823 |
| -2.1 | % |
For the three months ended June 30, |
| For the periods ended June 30, |
| |||||||||||||
Expenses: |
| 2024 |
| 2023 |
| % Change |
| 2024 |
| 2023 |
| % Change |
| |||
Commissions and fees |
| 33,352 |
| 32,914 |
| 1.3 | % | 67,007 |
| 67,998 |
| -1.5 | % | |||
Employee compensation and benefits |
| 3,594 |
| 3,287 |
| 9.4 | % | 7,051 |
| 6,787 |
| 3.9 | % | |||
Rent and occupancy |
| 290 |
| 312 |
| -7.2 | % | 585 |
| 616 |
| -5.0 | % | |||
Professional fees |
| 602 |
| 969 |
| -37.9 | % | 4,939 |
| 1,715 |
| 188.0 | % | |||
Technology fees |
| 480 |
| 408 |
| 17.7 | % | 842 |
| 945 |
| -10.9 | % | |||
Interest |
| 795 |
| 1,473 |
| -46.0 | % | 1,857 |
| 2,646 |
| -29.8 | % | |||
Depreciation and amortization |
| 293 |
| 334 |
| -12.3 | % | 594 |
| 610 |
| -2.6 | % | |||
Other |
| 1,765 |
| 365 |
| 383.6 | % | 1,187 |
| 773 |
| 53.6 | % | |||
Total expenses |
| 41,171 |
| 40,062 |
| 2.8 | % | 84,062 |
| 82,090 |
| 2.4 | % | |||
|
|
|
| |||||||||||||
Income (loss) before provision (benefit) for income taxes |
| (523) |
| 377 |
| -238.7 | % | (1,967) |
| 1,733 |
| -213.5 | % | |||
Provision ( benefit) for income taxes |
| 214 |
| 246 |
| -45.5 | % | 353 |
| 531 |
| -48.6 | % | |||
Net income (loss) | (736) | 131 |
| -601.4 | % | $ | (2,320) | $ | 1,202 |
| -286.4 | % |
Revenues
Wentworth’s primary source of revenue is from fees and commissions from products and advisory services offered by our advisors to their clients, a substantial portion of which we pay out to our advisors. We also generate interest income in accordance with our agreements with our clearing partners. In accordance with ASC 606, Revenue from Contracts with Customers, we record revenue when control of the promised services is transferred to customers in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Revenues are analyzed to determine whether the Company is the principal (i.e., reports revenues on a gross basis) or agent (i.e., reports revenues on a net basis) in the contract. Principal or agent designations depend primarily on the control an entity has over the product or service before control is transferred to a customer. The indicators of which party exercises control include primary responsibility over performance obligations, inventory risk before the good or service is transferred and discretion in establishing the price.
Commissions
Commission revenues represent sales commissions generated by advisors for their clients’ purchases and sales of securities on exchanges and over-the-counter, as well as purchases of other investment products.
23
The Company generates two types of commission revenues: sales-based commissions that are recognized at the point of sale on the trade date and trailing commissions that are recognized over time as earned. Sales-based commission revenues vary by investment product and are recognized on the trade date or the transaction date, which represents the completion of the Company’s performance obligation because that is when the underlying financial instrument or purchaser is identified, the pricing is agreed upon, and the risks and rewards of ownership have been transferred to/from the customer at a point in time. The rates at which commissions are charged to the customers range from 1% to 7% based on the investment product. Trailing commission revenues which are preliminarily related to the sales of mutual funds and variable annuities held by clients of the Company’s advisors are generally based on a percentage of the current market value of clients’ investment holdings in trail-eligible assets, and are recognized over the time the client owns the investment or holds the contract and is generally based on a fixed rate applied, generally twenty-five to fifty basis points (25-50 bps) of the current market value of the clients’ holdings. Trailing commissions are generally received monthly or quarterly. The ongoing revenue is not recognized at the time of sale because it is variably constrained due to factors outside the Company’s control including market volatility and the client’s investment hold period and the Company does not believe that it can overcome such constraints until the market value of the fund and the investor activities are known. The revenues will not be recognized until it is probable that a significant reversal will not occur.
The Company is principal for the commission revenue, as it is responsible for the execution of the clients’ purchases and sales and maintains relationships with the product sponsors. Advisors assist the Company in performing it obligations. Accordingly, total commission revenue is reported on a gross basis. See Note 4 - Revenues From Contracts with Customers within the notes to the condensed consolidated financial statements for the three and six-month periods ended June 30, 2024, and 2023 for further details regarding our commission revenue by product category.
The following tables sets forth the components of our commission revenue for the three and six-month periods ended June 30, 2024 and 2023 (in thousands):
| For the three-month period ended June 30, |
|
|
| |||||||
2024 |
| 2023 | $Change | % Change |
| ||||||
Sales-based | $ | 15,850 | $ | 21,964 |
| (6,214) |
| (28) | % | ||
Trailing |
| 17,813 |
| 11,358 |
| 6,456 |
| 57 | % | ||
Total commission revenue | $ | 33,663 | $ | 33,322 |
| 242 |
| 1 | % |
| For the six-month period ended June 30, |
|
|
|
|
| |||||
| 2024 |
| 2023 |
| $Change |
| % Change | ||||
Sales-based | $ | 31,617 | $ | 37,245 |
| (5,628) |
| (15) | % | ||
Trailing |
| 36,441 |
| 31,398 |
| 5,043 |
| 16 | % | ||
Total commission revenue | $ | 68,057 | $ | 68,643 |
| (585) |
| (1) | % |
Sales-based revenue decreased by approximately $6.2 million and $5.6 million or 28% and 15% for the three and six-month period ended June 30, 2024, respectively, as compared to 2023. Trailing based revenue increased by approximately $6.4 million and $5.0 million or 57% and 16% for the three and six-month periods ended June 30, 2024, respectively, as compared to 2023. The decrease in sales-based revenue for the three and six-month periods ended June 30, 2024 as compared to 2023 is attributable to a decrease in the generation of transactional based products. The increase in the trailing based revenues is primarily due to the net increase in trailing based assets and increase in the market performance Commission revenue is generated from brokerage assets. The following tables summarize the brokerage assets for the three and six-month periods ended June 30, 2024 and 2023 (in billions):
| As of June 30, | |||||
2024 |
| 2023 | ||||
Brokerage Assets | $ | 22.8 | $ | 21.1 |
Included in the brokerage assets above are trail-eligible assets as follows (in billions):
| As of June 30, | |||||
2024 |
| 2023 | ||||
Trail-Eligible Assets | $ | 16.3 | $ | 14.2 |
24
The following table summarizes activity impacting brokerage assets for the periods ended (in billions):
For the three month ended June 30, |
| For the six months ended June 30, | ||||||||||
Net Flows-Brokerage Assets |
| 2024 |
| 2023 |
| 2024 |
| 2023 | ||||
Balance – beginning of period | $ | 22.7 | $ | 20.5 | 21.8 | 20.1 | ||||||
Net new brokerage assets | $ | (0.8) | $ | (0.7) |
| (2.1) | (1.7) | |||||
Market impact | $ | 0.9 | $ | 1.3 |
| 3.1 | 2.7 | |||||
Balance – End of period | $ | 22.8 | $ | 21.1 | 22.8 | 21.1 |
(1) | Net new brokerage assets consist of total client deposits less client withdrawals from brokerage accounts, plus dividends, plus interest. |
(2) | Market impact is the difference between the beginning and ending asset balances less the net new asset amounts, representing the implied growth or decline in asset balances due to market change over the same period of time. |
Advisory Fees
Advisory fees represent fees charged to advisors’ clients’ accounts on the Company’s corporate advisory platform. The Company provides ongoing investment advice, brokerage and execution services on transactions, and performs administrative services for these accounts. These fees are recognized ratably over time to match the continued delivery of the performance obligations to the client over the life of the contract. The advisory fees generated from the Company’s corporate advisory platform are based on a percentage of the market value of the eligible assets in the clients’ advisory accounts.
Advisory fees increased by approximately 20.2% and 10.3% for the three and six-month periods ended June 30, 2024, respectively, as compared to the same periods in June 30, 2023, due to positive returns in the market offset by outflows of advisory assets.
The following tables summarizes the advisory assets for the three and six-month periods ended June 30, 2024 and 2023 (in billions):
| As of June 30 , | |||||
2024 |
| 2023 | ||||
Advisory Assets | $ | 2.3 | $ | 2.0 |
The following table summarizes activity impacting advisory assets for the periods ended (in billions):
| For the three month ended June 30, | For the six months ended June 30, | ||||||||||
Net Flows-Advisory Assets |
| 2024 |
| 2023 |
| 2024 |
| 2023 | ||||
Balance – beginning of period |
| $ | 2.2 | $ | 2.2 | 2.1 | 2.1 | |||||
Net new brokerage assets |
| $ | (0.0) | $ | (0.3) | (0.1) | (0.4) | |||||
Market impact |
| $ | 0.1 | $ | 0.1 | 0.3 | 0.3 | |||||
Balance – End of period |
| $ | 2.3 | $ | 2.0 | $ | 2.3 | $ | 2.0 |
(1) | Net new advisory assets consist of total client deposits less client withdrawals from custodial accounts, plus dividends, plus interest, minus advisory fees. |
(2) | Market impact is the difference between the beginning and ending asset balances less the net new asset amounts, representing the implied growth or decline in asset balances due to market change over the same period of time. |
Interest and other income
Interest income includes amounts earned on balances held at the Company’s clearing brokers related to cash balances and margin balances. The Company’s clearing agreements include provisions that provide for a sharing of the interest income earned on such balances with the clearing brokers. The rate varies based on the clearing broker.
Other income primarily includes amounts earned by the Company related to marketing and incentives earned from the sales of certain investment products by the financial advisors to its clients, primarily alternative investments, as well as sponsorship income.
The decrease in interest and other income for the period ended June 30, 2024, compared to 2023 is primarily related to a non-recurring income item that was earned in March 2023.
25
Operating Expenses
Commissions and Fees
Commissions and fees primarily consist of commissions paid to the financial advisors, technology costs associated with the platform for which the financial advisors operate their business, insurance costs and regulatory costs. Certain of the technology, insurance and regulatory costs are passed through to the financial advisors and any excess costs are included as fees within commissions and fees. The commissions and fees paid to the financial advisors are based on the advisory and commission revenue earned on each client’s account. The payout amount is production based, which is the gross revenue produced by the financial advisor, and varies based on the level of such production ranging from 50% to 95% of the revenue generated. The production levels begin at gross revenue of $15,000 up to $4,000,000 and up, and the payout rate starts at 50% and increases to a top payout rate of 94% for annual production of $4,000,000 and up.
The following table sets forth our payout rate, which is a statistical or operating measure and monitored to review that such costs of revenue remain consistent on a period over period basis:
| For the three months ended June 30, |
|
| ||||
2024 |
| 2023 |
| Change |
| ||
Payout range |
| 83.42 | % | 85.31 | % | (1.89) | % |
For the six months ended June 30, | ||||||
| 2024 |
| 2023 |
| Change | |
Payout range |
| 83.69 | % | 85.50 | % | (1.81) |
For the three and six-month periods ended June 30, 2024, the payout rate decreased as compared to 2023 as a result of in the prior year there was a non-recurring commissionable product that carried a payout at approximately 90%.
Employee compensation and benefits
Employee compensation and benefits includes salaries, wages, benefits and related taxes for our employees.
Employee compensation and benefits for the three-month period ended June 30, 2024 as compared to June 30, 2023, increased by approximately 9%.
Employee compensation and benefits for the six-month period ended June 30, 2024 as compared to June 30, 2023, increased by approximately 4%.
26
Rent and occupancy
Rent and occupancy for the three-month period ended June 30, 2024 as compared to June 30, 2023 decreasing by approximately 7%.
Rent and occupancy for the six-month period ended June 30, 2024 as compared to June 30, 2023 decreasing by approximately 5%.
Professional fees
Professional fees includes costs incurred related primarily to legal and accounting services. Professional fees for the three months ended June 30, 2024 decreased by $.4 million as compared to the 2023 resulting from a decrease in professional fees related to the Business Combination that occurred in March 2024. Professional fees for the six months ended June 30, 2024 increased by $3.2 million as compared to the 2023 which is directly related to transaction costs associated with the Business Combination.
Technology fees
Technology fees primarily represent infrastructure costs that support the Company’s technology and communications costs. Technology fees increase by $0.1 million for the three months ended June 30, 2024 as compared 2023 and decreased by $0.1 million for six months ended June 30, 2024, respectively, as compared to 2023.
Interest expense
Interest expense primarily includes interest associated with the Company’s credit facility and other debt obligations. Interest expense decreased by $0.7 million and $0.8 million for the three and six-month periods ended June 30, 2024, respectively, as compared to 2023 resulting from the repayment and restructuring of the related party debt obligations of Wentworth.
Depreciation and amortization
Depreciation and amortization relates to the use of property, equipment and leasehold improvements. Amortization also includes the amortization related to certain intangible assets.
Other expense
Other expense includes insurance, travel-related expenses, office expenses, marketing and other miscellaneous expenses.
Provision for Income Taxes
Our effective income tax rate was (29.0)% and (15.2)% for the three and six-month periods ended June 30, 2024, as compared to 187.8% and 44.2% for the same periods in 2023, respectively. The difference in our effective tax rate was related to the transaction expenses related to the Reverse Recapitalization.
Liquidity and capital resources
We have established liquidity policies intended to support the execution of strategic initiatives, while meeting regulatory capital requirements and maintaining ongoing and sufficient liquidity. We believe liquidity is of critical importance to the Company and, in particular, to our broker-dealer subsidiaries, PKSI, CLS, MSI and WEG. The objective of our policies is to ensure that we can meet our strategic, operational and regulatory liquidity and capital requirements under both normal operating conditions and under periods of stress in the financial markets.
Parent Company Liquidity
Binah Capital Group, Inc. through its indirectly wholly owned subsidiary Wentworth Management Services LLC, is the direct holding company of our operating subsidiaries, and considers its primary sources of liquidity to be dividends and management fees from our operating subsidiaries.
27
Sources of Liquidity
As of June 30, 2024, we had $19.7 million outstanding under our Senior Credit Facility with Oak Street Funding, LLC, net of debt issuance costs. The associated debt facilities are as follows:
Oak Street Funding, LLC
On April 2, 2020, the Company entered into a Credit Agreement (the “Credit Agreement”) with Oak Street Funding LLC (“Oak Street”) in the amount of $25 million. This note payable bears interest at the prime rate (“Prime”) (8.50% as of June 30, 2024) plus 2.25% and has a 10-year term and a 3-month interest only repayment provision. As of June 30, 2024 and December 31, 2023, the outstanding balance of the Oak Street note, net of unamortized debt issuance costs was $16.7 million and $17.6 million, respectively.
On April 25, 2021, the Company entered into an additional promissory note with Oak Street in the amount of $4.1 million related to the acquisition of WEG (“WEG Note”). This note payable bears interest at Prime plus 2.25% and has a 10-year term. As of June 30, 2024 and December 31, 2023, the outstanding balance of this note, net of unamortized debt issuance costs was $3.0 million and $3.2 million, respectively.
Under the Oak Street notes, the Company is subject to certain covenants as defined in the agreements. As of June 30, 2024 and December 31, 2023, the Company was in compliance with all financial related covenants.
The minimum payments and maturities of the Oak Street notes as of June 30, 2024 were as follows (in thousands):
2024 |
| $ | 1,220 |
2025 | 2,669 | ||
2026 |
| 2,993 | |
2027 |
| 3,354 | |
2028 |
| 3,757 | |
Thereafter |
| 6,306 | |
Total | $ | 20,299 |
Redeemable Convertible Preferred Stock
On March 15, 2024 (the “Funding Date”) in connection with the consummation of the Business Combination, Holdings and Wentworth entered into a Subscription Agreement with an investor for the purchase of 1,500,000 shares of Holdings’ Series A Redeemable Convertible Preferred Stock (the “Holdings Series A Stock”) in a private placement at $9.60 per share, for an aggregate purchase price of $14,400,000 (the “Series A PIPE”). The Holdings Series A Stock may be converted into shares of Holdings Common Stock after the second anniversary of the closing of the Series A PIPE, which such conversion shall initially be 1.5 shares of Holdings Common Stock for each share of Series A Convertible Preferred Stock, subject to certain adjustments provided in the Certificate of Designations.
Additionally, the Holdings Series A Stock carries a cumulative dividend at a rate of nine percent (9%) per annum, payable and compounded quarterly on the last day of each quarter. At the discretion of Holdings the payment may be made in cash or up to 50% of the amount due, in duly authorized, validly issued, fully paid and non-assessable share of Holdings Series A Stock at a value of $10 per share.
The Holdings Series A Stock has liquidation preferences in the event of a voluntary or involuntary liquidation as follows:
● | The greater of $12.50 per share of Holdings Series A Stock if such liquidation occurs prior to the first anniversary of the Funding Date; |
● | $13.00 per share of Holdings Series A Stock if such liquidation occurs prior to the second anniversary of the Funding Date; |
● | $15.00 per share of Holdings Series A Stock if such liquidation occurs prior to the third anniversary of the Funding Date; |
● | $16.00 per share of Holdings Series A Stock if such liquidation occurs prior to the fourth anniversary of the Funding Date. |
28
Holdings, at its option, may redeem the Series A Stock on any anniversary of the Funding date up to an including the fourth anniversary of the Funding date at the following redemption prices:
● | $11.50 per share of Series A Stock on the first anniversary of the Funding Date; |
● | $13.00 per share of Series A Stock on the second anniversary of the Funding Date; |
● | $15.00 per share of Series A Stock on the third anniversary of the Funding Date; |
● | $16.00 per share of Series A Stock on the fourth anniversary of the Funding Date; |
If the Series A Stock have not previously been redeemed or converted, the Series A Stock will be redeemed by Holdings on the fourth anniversary of the Funding Date.
Other promissory notes
On November 30, 2017, Wentworth issued subordinated promissory notes in the aggregate principal amount of approximately $3.6 million to certain sellers in connection with the acquisition of the PKSH Entities. These notes had a maturity date of May 17, 2023 and accrued interest at a rate of 10% annually. The interest on these notes continued to accrue until such time as these notes were paid or restructured.
Contingent consideration subordinated promissory notes
Additionally, in connection with the acquisition of the PKSH Entities, Wentworth agreed to pay contingent consideration in the amount of $5.0 million to certain sellers. The conditions related to this contingency were met on November 30, 2018, and thus the notes had been issued to the sellers. These subordinated promissory notes had a maturity date of May 30, 2023, and accrued interest at a rate of 10% annually. The interest on these notes continued to accrue until such time as these notes were paid or restructured.
As of December 31, 2023, the amount of principal and accrued interest related to these promissory notes was approximately $12.2 million. Related interest expense was approximately $0 million and $0.3 million for the six months ended June 30, 2024 and 2023, respectively.
In connection with the closing of the Business Combination, the Company paid approximately $3.5 million on these notes. In addition to the paydown, the noteholders agreed to forgive the remaining accrued but unpaid interest of approximately $3.8 million and entered into new promissory notes in the principal amount of approximately $5.3 million in the aggregate. The terms of these new promissory notes provide for maturity on May 15, 2027 and carries an interest rate of Prime plus 1.00%, but no less than 7.50% per annum. Related interest expense was approximately $0.1 and $0 for the six months ended June 30, 2024 and 2023, respectively.
Other commitments
Wentworth had entered into promissory notes with certain of its members to provide for working capital. As of December 31, 2023, the amount of principal and accrued interest related to these notes were approximately $5.2 million. The notes carried an interest at the rate of 10% and were due on demand.
In connection with the closing of the Business Combination, the noteholders agreed to satisfy all outstanding obligations, including the payment of principal and interest, in exchange for an amount of cash equal to approximately $0.9 million, forgiveness of certain other obligations owed to a noteholder and the issuance of 357,000 shares of Common Stock of Binah Capital Group, Inc.
Cash Flows
The following table sets forth a summary of cash flows for the six month period ended June 30, 2024 and 2023:
(in thousands) | 2024 |
| 2023 | |||
Net cash (used in) provided by operating activities | $ | (2,115) | $ | 204 | ||
Net cash used in investing activities |
| (18) |
| (88) | ||
Net cash provided by (used in) financial activities |
| 1,535 |
| (1,259) | ||
Net change in cash flows | $ | (598) | $ | (1,143) |
29
Cash Flows from Operating Activities. Net cash used in operating activities was $2.1 million for the six-month period ended June 30, 2024, compared to net cash provided by of $0.2 million for the six-month period ended June 30 2023, representing a decrease of approximately $2.3 million. The decrease was primarily attributable to the decrease in net income of approximately $1.2 million to a net loss of $2.2 million or a change of $3.4 million.
Cash Flows from Investing Activities. Net cash used in investing activities was $0.0 million for the six-month period ended June 30, 2024, compared to $0.1 million for the six-month period ended June 30, 2023. The decrease was primarily related to the decrease in the purchases of property and equipment.
Cash Flows from Financing Activities. Net cash provided by financing activities was approximately $1.3 million for the six-month period ended June 30, 2024 compared to cash used in financing activities of approximately $1.3 million for the six-month period ended June 30, 2023. The change is primarily related to the proceeds received from the Redeemable Convertible Preferred Financing offset by the repayments of the Wentworth related party debt obligations.
Contractual Obligations and Commitments
The following table summarizes our contractual obligations and other commitments as of June 30, 2024:
| Payments Due by period | ||||||||||||||
Total |
| Less than 1 Year |
| 1-3 Years |
| 3-5 Years |
| More than 5 Years | |||||||
Contractual obligations |
| (in thousands) | |||||||||||||
Long-term debt obligations (1) | $ | 20,299 | $ | 1,220 | $ | 9,016 | $ | 9,900 | $ | 163 | |||||
Interest payments |
| 8,829 |
| 2,127 |
| 5,142 |
| 1,554 |
| 6 | |||||
Promissory notes – affiliates (2) |
| 5,463 |
| — |
| 5,463 |
| — |
| — | |||||
Operating lease obligations (3) |
| 4,501 |
| 535 |
| 1,662 |
| 1,764 |
| 540 | |||||
$ | 39,092 | $ | 3,882 | $ | 21,283 | $ | 13,218 | $ | 710 |
(1) | Represents principal obligations related to the Oak Street credit facility that was entered into during the years ended December 31, 2020 and 2021. |
(2) | Represents the obligations under the amounts due to certain sellers of the PKSH entities. |
(3) | Represents future minimum lease payments as of June 30, 2024, under non-cancelable office leases. |
Critical Accounting Policies and Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Although these estimates are based on the Company’s knowledge of current events and actions the Company may undertake in the future, actual results could differ from those estimates and assumptions.
We define our critical accounting policies and estimates as those that require us to make subjective judgments about matters that are uncertain and are likely to have a material impact on our financial condition and results of operations as well as the specific manner in which we apply those principles. We believe the critical accounting policies used in the preparation of our financial statements which require significant estimates and judgments are as follows:
Revenue Recognition
Revenues from contracts with customers are recognized when control of the promised services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. Management exercises judgment in determining whether the Company is the principal (i.e., reports revenues on a gross basis) or agent (i.e., reports revenue on a net basis). For additional information see Note 4 in the consolidated financial statements as of and for the three and six-months periods ended June 30, 2024 and 2023.
30
Goodwill and Other Intangible Assets
Goodwill and other intangible assets are tested annually for impairment or if certain events occur indicating that the carrying amounts may be impaired. We have the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events or circumstances, we determine it is more likely than not that the fair value of a reporting unit is greater than its carrying amount, then performing the two-step impairment test is not required. However, if we conclude otherwise, we are then required to perform the first step of the two-step impairment test. Goodwill impairment is determined by comparing the estimated fair value of a reporting unit with its respective carrying value. If the estimated fair value exceeds the carrying value, goodwill at the reporting unit level is not deemed to be impaired. If the estimated fair value is below carrying value, however, further analysis is required to determine the amount of the impairment. Additionally, if the carrying value of a reporting unit is zero or a negative value and it is determined that it is more likely than not the goodwill is impaired, further analysis is required. The estimated fair values of the reporting units are derived based on valuation techniques we believe market participants would use for each of the reporting units.
We performed our goodwill impairment test as of and for the years ended December 31, 2023, and 2022. The estimated fair value of the reporting units were determined using the market approach for each reporting unit, relying specifically on the guideline public company method. Our guideline public company method incorporates revenue and earnings multiples from publicly traded companies with operations and other characteristics similar to each reporting unit. As a result of the 2023 and 2022 annual impairment tests, the fair value of the reporting units was 257% and 266% greater than its carrying value, respectively. Since there have been no events or circumstances which indicated that it was more likely than not the fair value of the reporting units were below their carrying amount, interim goodwill tests were not considered necessary.
The goodwill impairment test requires us to make judgments in determining what assumptions to use in the calculation. Assumptions, judgments, and estimates about future cash flows and discount rates are complex and often subjective. They can be affected by a variety of factors, including, among others, economic trends and market conditions, changes in revenue growth trends or business strategies, unanticipated competition, discount rates, technology, or government regulations. In assessing the fair value of our reporting units, the volatile nature of the securities markets and industry requires us to consider the business and market cycle and assess the stage of the cycle in estimating the timing and extent of future cash flows. In addition to discounted cash flows, we consider other information, such as public market comparable and multiples of recent mergers and acquisitions of similar businesses. Although we believe the assumptions, judgments, and estimates we have made in the past have been reasonable and appropriate, different assumptions, judgments, and estimates could materially affect our reported financial results.
Intangible assets that are deemed to have definite lives are amortized over their useful lives, generally ranging from 5 to 10 years. They are reviewed for impairment when there is evidence that events or changes in circumstances indicate that the carrying amount may not be recoverable. Recoverability of assets to be held and used is measured by comparing the carrying amount to the estimated undiscounted future cash flows expected to be generated. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the estimated fair value.
Contingent Liabilities
The Company recognizes liabilities for contingencies when there is an exposure that, when fully analyzed, indicates potential losses become probable and can be reasonably estimated. Whether a potential loss is probable and can be reasonably estimated is based on currently available information and is subject to significant judgment, a variety of assumptions and uncertainties.
When a potential loss is probable and the loss or range of loss can be estimated, the Company will accrue the most likely amount within that range. No liability is recognized for those matters which, in management’s judgment, the determination of a reasonable estimate of potential loss is not possible, or for which a potential loss is not determined to be probable.
Recently Issued Accounting Pronouncements
Refer to Note 2 - Summary of Significant Accounting Policies, within the notes to the consolidated financial statements for a discussion of recent accounting pronouncements or changes in accounting pronouncements that are of significance, or potential significance, to us.
31
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in market risk from those addressed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023 during the three months ended June 30, 2024. See the information set forth in Part II, Item 7A, Quantitative and Qualitative Disclosures About Market Risk, of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our principal executive officer and principal financial and accounting officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of June 30, 2024, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial and accounting officer have concluded that as of June 30, 2024, our disclosure controls and procedures were effective.
Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
32
PART II—OTHER INFORMATION
Item 1. Legal Proceedings.
We may be party to various claims and legal proceedings from time to time. We are not subject to any pending material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us or any of our officers or directors in their capacity as such.
From time to time, we have been subjected to and are currently subject to legal and regulatory proceedings arising out of our business operations, including lawsuits, arbitration claims and inquiries, investigations and enforcement proceedings initiated by the SEC, FINRA and state securities regulators, as well as other actions and claims.
Item 1A. Risk Factors.
There have been no material changes to the information previously disclosed in “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
None.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not Applicable.
Item 5. Other Information.
Gould Employment Agreement
On August 14, 2024,
Mr. Gould’s 2024 annual base salary is $600,000. In addition, the Company may provide Mr. Gould a discretionary year-end performance-based bonus which will not be less than the bonus paid to any other executive of the Company. Mr. Gould’s performance and the Company’s performance are to be primary considerations in determining any such annual bonus, which is subject to his continuous employment December 31 of the relevant bonus year, with such bonus payable no later than March 31 of the year following the relevant bonus year.
No later than September 15, 2024, the Company will grant Mr. Gould nonqualified stock options to purchase 600,000 shares of common stock of the Company, subject to any reasonable capitalization adjustments before the date of grant, under the terms of the Company’s 2024 Equity Incentive Plan, as may be amended from time to time (the “Plan”). These initial options will be exercisable for a period of ten (10) years, subject to earlier termination in accordance with the option agreement and Plan. The exercise price of these initial options will be equal to the fair market value of the Company’s common Stock on the date of grant. The vesting schedule of these initial options will be as follows: (a) one-third of the Initial Options will vest on December 31, 2024, based on continued service through such date; and (b) two-thirds of the Initial Options will vest ratably on a monthly basis over the remainder of Mr. Gould’s initial term based on continued service through each vesting date, with the first such vesting date being on January 31, 2025. The Initial Options will accelerate and be deemed vested in full upon a Change in Control as defined in the Plan.
33
On each anniversary of the Closing or May 15, 2024, the Company will grant Mr. Gould nonqualified stock options to purchase that number of shares of common stock of the Company which have a grant date fair value equal to his then annual base salary amount, as reasonably determined by the Board, under the terms of the Plan. These additional options will be exercisable for a period of ten (10) years, subject to earlier termination in accordance with the option agreement and Plan. The exercise price of these additional options will be equal to the fair market value of the Company’s common Stock on the date of grant. The vesting schedule of these additional options will be ratable monthly over three years from the date of the grant. The additional options will accelerate and be deemed vested in full upon a Change in Control as defined in the Plan.
After the filing of a registration statement on Form S-8 for the Plan, the Company will grant Mr. Gould, subject to his continuous service, 500,000 restricted stock units settled in shares of common stock of the Company, subject to any reasonable capitalization adjustments before the date of grant, with one-half of the grant vesting on the first anniversary of the date of grant and the remainder of the grant vesting on the second anniversary of the date of grant based on Mr. Gould’s continued service through each vesting date.
During 2024, after the filing of a registration statement on Form S-8 for the Plan, the Company will grant to Mr. Gould, subject to his continuous service, a fully vested share grant with a grant date fair market value of $220,000. If, during 2025, Mr. Gould continues to provide a personal guarantee on Company debt, the Company will grant Mr. Gould, subject to his continuous service, a fully vested share grant with a grant date fair market value of $220,000.
All options granted by the Company will be forfeited upon Mr. Gould’s termination for Cause. All option grants will be subject to the terms of the applicable option agreement and Plan.
If the Company terminates Mr. Gould’s employment without Cause, or Mr. Gould resigns for Good Reason Mr. Gould is entitled to (i) three times the amount of Mr. Gould’s base compensation and three times the amount of the annual bonus payment paid to Mr. Gould for the bonus year prior to the year in which termination occurs, payable in a lump-sum payment on the first regular payday occurring 60 days following the termination date, and (ii) accelerated vesting of all outstanding options as of the effective date of Mr. Gould’s termination. In addition, in the event that Mr. Gould resigns other than for Good Reason, or the Gould Agreement is not renewed upon expiration of the applicable term, Mr. Gould will receive a payment equal to his then-current annual base salary and target annual bonus, payable in a lump sum payment on the first regular payday occurring 60 days following the termination date, in exchange for Mr. Gould being bound to a non-competition agreement. Mr. Gould will only receive these severance payments if Mr. Gould executes a full general and mutual release in a form acceptable to the Company and Mr. Gould, and such release has become effective in accordance with its terms prior to the 60th day following the termination date. All other obligations to Mr. Gould will be automatically terminated and completely extinguished.
If Mr. Gould’s employment with the Company terminates due to (x) Mr. Gould’s death, (y) Mr. Gould’s inability to perform the essential functions of his position with or without reasonable accommodation, (z) termination by the Company for Cause, Mr. Gould will not be entitled to the severance payments in the prior paragraph and will only be entitled to receive base salary and benefits accrued through the termination date. If Mr. Gould’s employment terminates due to Mr. Gould’s disability or death, Mr. Gould will also be entitled to accelerated vesting of all stock or other options that are unvested as of the termination date.
For this purpose, “Cause” is defined as any of the following: (i) conviction of or a plea of nolo contendere to any felony or any misdemeanor that involves crimes of moral turpitude, fraud or theft; or (i) the material breach by Mr. Gould of any of his obligations, duties and/or covenants under the Gould Agreement if such breach causes material damage to the Company, which breach, if curable, continues following written notice from the Company describing same with particularity and expiration of a 60-day cure period. “Good Reason” is defined as any of the following, without Mr. Gould’s written consent: (i) a material diminution in Mr. Gould’s responsibilities, authority or duties; (ii) a diminution in Mr. Gould’s base salary or target annual bonus amount; or (iii) the material breach by the Company of any material provision of the Gould Agreement or other written agreement between the Company and Mr. Gould, provided that a Good Reason Process has been followed prior to termination. “Good Reason Process” shall mean that (i) Mr. Gould reasonably determines in good faith that one of the Good Reason prongs has occurred; (ii) Mr. Gould has notified the Company of such occurrence in writing within 30 days of the occurrence; (iii) Mr. Gould cooperates in good faith with the Company’s efforts, for a period not less than 30 days following such notice (the “Cure Period”), to remedy the condition; (iv) notwithstanding such efforts, the occurrence of the Good Reason continues to exist; and (v) Mr. Gould terminates his employment within 30 days after the end of the Cure Period.
34
If Mr. Gould’s employment is terminated for any reason, he is subject to: ongoing confidentiality and non-disclosure obligations; and 12-month, post-termination restrictive covenants of non-solicitation of employees, and customers Mr. Gould will be subject to a 12-month, post-termination non-competition clause, provided that if his initial or renewal term is not extended or where he resigns without Good Reason, he must be compensated for the restricted period in order for the non-competition clause to be enforceable. Each of the non-solicitation and non-competition provisions, as applicable, will be extended by one day for each day that Mr. Gould is deemed by a court or other tribunal to have violated any such restrictive covenants.
Shane Employment Agreement
On August 14, 2024, the Company entered into an executive employment agreement with David Shane, the Company’s Chief Financial Officer (the “Shane Agreement”). The Shane Agreement will be for an initial, three-year term which will automatically renew for additional, consecutive one-year terms unless either party provides the other party with 60 days’ notice of the intent not to renew prior to the expiration of the applicable term. Notwithstanding the foregoing, Mr. Shane’s employment is “at-will” and the Shane Agreement may be terminated at any time, by either party, with or without Cause (as defined below) or advance notice.
Mr. Shane’s 2024 annual base salary is $400,000. In addition, the Company may provide Mr. Shane a discretionary year-end performance-based bonus with a 2024 bonus target of 100% of his annual base salary. For calendar year 2024, Mr. Shane is guaranteed a bonus of no less than $350,000, and Mr. Shane may be eligible for a bonus of up to 200% of his annual base salary, based on Mr. Shane’s exceptional performance during such year. Mr. Shane’s performance and the Company’s performance are to be primary considerations in determining any such annual bonus, which is subject to his continuous employment through December 31 of the relevant bonus year, with such bonus payable no later than March 31 of the year following the relevant bonus year.
No later than September 15, 2024, the Company will grant Mr. Shane nonqualified stock options to purchase 250,000 shares of common stock of the Company, subject to any reasonable capitalization adjustments before the date of grant (the “Initial Options”), under the terms of the Plan. These initial options will be exercisable for a period of ten (10) years, subject to earlier termination in accordance with the option agreement and Plan. The exercise price of these initial options will be equal to the fair market value of the Company’s common stock on the date of grant. The vesting schedule of these initial options will be as follows: (a) one-third of the Initial Options will vest on December 31, 2024, based on continued service through such date; and (b) two-thirds of the Initial Options will vest ratably on a monthly basis over the remainder of Mr. Shane’s initial term based on continued service through each vesting date, with the first such vesting date being on January 31, 2025. The Initial Options will accelerate and be deemed vested in full upon a Change in Control as defined in the Plan.
On the May 15, 2024, May 15, 2025, and May 15, 2026, the Company will grant Mr. Shane nonqualified stock options to purchase that number of shares of common stock of the Company which have a grant date fair value equal to $350,000, as reasonably determined by the Board, under the terms of the Plan. These additional options will be exercisable for a period of ten (10) years, subject to earlier termination in accordance with the option agreement and Plan. The exercise price of these additional options will be equal to the fair market value of the Company’s common stock on the date of grant. The vesting schedule of these additional options will be ratable monthly over three years from the date of the grant. The additional options will accelerate and be deemed vested in full upon a Change in Control as defined in the Plan.
All options granted by the Company will be forfeited upon Mr. Shane’s termination for Cause. All option grants will be subject to the terms of the applicable option agreement and Plan.
If the Company terminates Mr. Shane’s employment without Cause or Mr. Shane resigns for Good Reason, Mr. Shane is entitled to (i) Mr. Shane’s then current base salary and target annual bonus amounts that would be payable during the greater of (A) the remainder of the applicable term but for such termination, or (B) the Restricted Period (as defined in Section 13.2 of the Shane Agreement), payable in a lump-sum payment on the first regular payday occurring 60 days following the termination date, and (ii) accelerated vesting of all outstanding options as of the effective date of Mr. Shane’s termination. In addition, in the event that Mr. Shane resigns other than for Good Reason, or the Shane Agreement is not renewed upon expiration of the applicable term, Mr. Shane will receive a payment equal to his then-current annual base salary and target annual bonus, payable in a lump sum payment on the first regular payday occurring 60 days following the termination date, in exchange for Mr. Shane being bound to a non-competition agreement. Mr. Shane will only receive these severance payments if Mr. Shane executes a full general and mutual release in a form acceptable to the Company and Mr. Shane, and such release has become effective in accordance with its terms prior to the 60th day following the termination date. All other obligations to Mr. Shane will be automatically terminated and completely extinguished.
35
If Mr. Shane’s employment with the Company terminates due to (x) Mr. Shane’s death, (y) Mr. Shane’s inability to perform the essential functions of his position with or without reasonable accommodation, or (z) termination by the Company for Cause, Mr. Shane will not be entitled to the severance payments in the prior paragraph and will only be entitled to receive base salary and benefits accrued through the termination date.
For this purpose, “Cause” is defined as any of the following: (i) conviction of or a plea of nolo contendere to any felony or any misdemeanor that involves crimes of moral turpitude, fraud or theft; or (i) the material breach by Mr. Shane of any of his obligations, duties and/or covenants under the Shane Agreement if such breach causes material damage to the Company, which breach, if curable, continues following written notice from the Company describing same with particularity and expiration of a 30-day cure period.
“Good Reason” is defined as any of the following, without Mr. Shane’s written consent: (i) a material diminution in Mr. Shane’s responsibilities, authority or duties; (ii) a diminution in Mr. Shane’s base salary or target annual bonus amount; or (iii) the material breach by the Company of any material provision of the Shane Agreement or other written agreement between the Company and Mr. Shane, provided that a Good Reason Process has been followed prior to termination. “Good Reason Process” shall mean that (i) Mr. Shane reasonably determines in good faith that one of the Good Reason prongs has occurred; (ii) Mr. Shane has notified the Company of such occurrence in writing within 30 days of the occurrence; (iii) Mr. Shane cooperates in good faith with the Company’s efforts, for a period not less than 30 days following such notice (the “Cure Period”), to remedy the condition; (iv) notwithstanding such efforts, the occurrence of the Good Reason continues to exist; and (v) Mr. Shane terminates his employment within 30 days after the end of the Cure Period.
If Mr. Shane’s employment is terminated for any reason, he is subject to: ongoing confidentiality and non-disclosure obligations; and 12-month, post-termination restrictive covenants of non-solicitation of employees and customers. Mr. Shane will be subject to a 12-month, post-termination non-competition clause, provided that if his initial or renewal term is not extended or where he resigns without Good Reason, he must be compensated for the restricted period in order for the non-competition clause to be enforceable. Each of the non-solicitation and non-competition provisions, as applicable, will be extended by one day for each day that Mr. Shane is deemed by a court or other tribunal to have violated any such restrictive covenants.
36
Item 6. Exhibits
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
Exhibit |
| Description of Document |
10.1*†, + | ||
10.2*†, + | ||
31.1* | ||
31.2* | ||
32.1** | ||
32.2** | ||
101.INS | XBRL Instance Document | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | |
101.SCH | XBRL Taxonomy Extension Schema Document | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | |
101.LAB | XBRL Taxonomy Extension Labels Linkbase Document | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | |
104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |
* Filed herewith
** Furnished herewith
∔ Certain identified information has been excluded from the exhibit pursuant to Item 601(a)(6) and/or Item 601(b)(10)(iv) of Regulation S-K.
† Indicates a management contract or compensatory plan or arrangement.
37
SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BINAH CAPITAL GROUP, INC. | ||
Date: August 14, 2024 | By: | /s/ Craig Gould |
Name: | Craig Gould | |
Title: | Chief Executive Officer | |
(Principal Executive Officer) | ||
Date: August 14, 2024 | By: | /s/ David Shane |
Name: | David Shane | |
Title: | Chief Financial Officer | |
(Principal Accounting and Financial Officer) |
38
Exhibit 10.1
EXECUTIVE EMPLOYMENT AGREEMENT
This Executive Employment Agreement (this “Agreement”) is made as of August 14, 2024 (“Effective Date”), by and between Binah Capital Group, Inc., a Delaware corporation (“Company”), and Craig Gould, an individual (“Executive”). Each of the Company and Executive is a “Party,” and collectively, they are the “Parties.”
WHEREAS, Executive is currently employed as President of Wentworth Management Services, LLC (“Wentworth”) and as President and Chief Executive Officer of Cabot Lodge Securities (“Cabot Lodge”);
WHEREAS, following the closing of the SPAC transaction (the “Closing”), Wentworth is a subsidiary of the Company, which is a successor to Kingswood Acquisition Corporation;
WHEREAS, the Company desires to employ Executive in the position of Chief Executive Officer, and Executive desires to accept such offer;
WHEREAS, as of the Effective Date, the Parties agree that Executive, and Executive’s employment agreements with Wentworth and Cabot Lodge will be superseded hereby;
NOW, THEREFORE, in consideration of the mutual promises and agreements contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows commencing on the Effective Date:
1.Employment. The Company hereby employs Executive, and Executive hereby accepts such employment, upon the terms and conditions set forth herein.
2.Duties.
2.1Position. Executive is employed as the Chief Executive Officer of the Company. Executive will report to the Company’s Board of Directors (“Board”) and will have the duties and responsibilities assigned by the Board and consistent with such position. Executive will perform faithfully and diligently all duties assigned to Executive.
2.2Best Efforts/Full-time. Executive will expend Executive’s best efforts on behalf of the Company and will abide by all of the Company’s policies and by applicable federal, state and local laws, regulations or ordinances. Executive will act in the best interest of the Company at all times. Executive will devote Executive’s full business time and efforts to the performance of Executive’s assigned duties for the Company, unless Executive notifies the Board in advance of Executive’s intent to engage in other paid work and receives express written consent from such individual to do so. Notwithstanding the foregoing, Executive will be permitted to (i) engage in the activities listed on Exhibit A hereto (as such exhibit may be amended from time to time with the written agreement of Executive and the Board), and (ii) serve as an outside director on the board of directors for nonprofit or charitable entities or manage Executive’s personal financial and legal affairs; in each case, so long as the foregoing activities are not competitive with the Company and subject to the provisions of Section 10 below.
[***] Indicates material that has been excluded from this Exhibit 10.1 because it is not material.
2.3 Work Location. Executive’s principal place of work will be located in Chicago, Illinois, or such other location as the Company may direct from time to time in connection with the performance of Executive’s duties. Executive may work remotely from time to time from locations in the continental United States.
3.Term. Executive’s employment will commence, and this Agreement will be effective as of the Effective Date and will continue for a term of five (5) years thereafter (the “Initial Term”), unless extended or earlier terminated as provided in this Agreement. At least sixty (60) days prior to the expiration of the Initial Term or Renewal Term (defined below), the Executive shall notify the Board of whether the Executive would like to renew this agreement (the “Renewal Notice”) for a successive three (3) year period following the last day of the Initial Term. The Board will consider whether to offer the Executive an extension under this Agreement (such three-year extension, a “Renewal Term”). If the Board decides in its sole and absolute discretion to approve the Renewal Notice, it will notify the Executive accordingly (the “Renewal Approval”), not less than thirty (30) days prior to the expiration of the Initial Term or Renewal Term, as applicable. Each subsequent Renewal Term will renew, subject to a timely Renewal Notice and Renewal Approval for each additional Renewal Term, on the last day of each Renewal Term (each, Renewal Term together with the Initial Term, the “Term”). During any Renewal Term, the terms, conditions and provisions set forth in this Agreement will remain in effect unless modified in accordance with the terms of this Agreement. Notwithstanding the foregoing, Executive’s employment with the Company is at-will and may be terminated at any time, with or without Cause (as defined below) or advance notice, by either Executive or the Company, subject to the provisions regarding termination set forth below in Section 7.
4.Compensation.
4.1Base Salary. As compensation for Executive’s performance of Executive’s duties hereunder, the Company will pay to Executive an annualized salary of $600,000, less applicable withholdings and deductions, payable in accordance with the normal payroll practices of the Company. Beginning in calendar year 2025, the Company’s Compensation Committee will conduct an annual review of Executive’s base salary based on third party comparison data and internal management recommendations. Executive’s base salary may be increased but may not be decreased without Executive’s prior written approval.
4.2Incentive Compensation. Beginning in calendar year 2024, Executive will be eligible to earn an annual incentive bonus based on criteria similar to other senior executives of the Company (the “Annual Bonus”), provided that whether Executive receives an Annual Bonus, and the criteria used to determine the amount of such Annual Bonus, will be at the sole discretion of the Board but will not be less than the annual bonus of any other executive of the Company. The Annual Bonus payment will be less all required taxes and withholdings and, if earned by Executive, paid out in the next year no later than March 31 of such year following the year for which the bonus is earned. For avoidance of doubt, Executive will be entitled to any Annual Bonus that has been earned with respect to a particular bonus year so long as he is employed on December 31 of such year (regardless of whether he is employed on the date on which such Annual Bonus is actually paid).
4.4Equity Compensation.
(a)No later than six (6) months after the Closing, but after the filing of an S-8 registration statement for the Plan (as defined herein), subject to Executive’s continuous service through the grant date, the Company will grant Executive nonqualified stock options to purchase 600,000 shares of Common Stock of the Company, subject to any reasonable capitalization adjustments before the date of grant (the “Initial Options”), under the terms of the Company’s 2024 Equity Incentive Plan, as may be amended from time to time (the “Plan”). The Initial Options will be exercisable for a period of ten (10) years, subject to earlier termination in accordance with the option agreement and Plan. The exercise price of the Initial Options will be equal to the fair market value of the Company’s Common Stock on the date of grant. The vesting schedule of the Initial Options will be as follows: 1/3 of the Initial Options will vest on December 31, 2024, and the remaining 2/3 of the Initial Options ratably on the last day of each calendar month following the initial vesting date through December 31, 2026, based on continued service through each vesting date, with the first such monthly vesting date being on January 31, 2025; provided, however, that the Initial Options will accelerate and be deemed vested in full upon a Change in Control (as defined in the Plan).
(b)On each anniversary of the Closing, subject to Executive’s continuous service through the grant date, the Company will grant Executive nonqualified stock options to purchase that number of shares of Common Stock of the Company which have a grant date fair value equal to Executive’s annual base salary at the time of each such grant, as reasonably determined by the Board (the “Additional Options”), under the terms of the Plan. The Additional Options will be exercisable for a period of ten (10) years, subject to earlier termination in accordance with the option agreement and Plan. The exercise price of the Additional Options will be equal to the fair market value of the Company’s Common Stock on the date of grant. The vesting schedule of the Additional Options will be ratable monthly over three years from the date of the grant, subject to accelerated vesting upon a Change in Control, as defined in the Plan, based on continued service through each vesting date; provided, however, that the Additional Options will accelerate and be deemed vested in full upon a Change in Control (as defined in the Plan).
(c)The Initial Options and the Additional Options will be granted pursuant to options award agreements that include a cashless exercise provision.
(d)After the filing of a registration statement on Form S-8 for the Plan, subject to Executive’s continuous service through the grant date, the Company will grant to Executive 500,000 restricted stock units settled in shares of Common Stock of the Company, subject to any reasonable capitalization adjustments before the date of grant, with one-half of the grant vesting on the first anniversary of the date of grant and the remainder of the grant vesting on the second anniversary of the date of grant based on Executive’s continued service through each vesting date.
(e)During 2024, after the filing of a registration statement on Form S-8 for the Plan, during Executive’s continuous service, the Company will grant to Executive a fully vested share grant with a grant date fair market value of $220,000. If, during 2025, Executive continues to provide a personal guarantee on Company debt, during Executive’s continuous service, the
Company will grant to Executive a fully vested share grant with a grant date fair market value of $220,000.
5.Benefits.
5.1Customary Fringe Benefits. Executive will be eligible for all customary and usual fringe benefits generally available to executives of the Company, subject to the terms and conditions of the Company’s benefit plan documents. The Company reserves the right to change or eliminate the fringe benefits on a prospective basis, at any time, effective upon notice to Executive.
5.2Vacation. Executive will be provided with the greater of (a) four (4) weeks’ paid vacation per calendar year, or (b) such greater amount of paid vacation weeks per calendar year as may be provided for pursuant to the Company’s vacation policy then in effect. Any accrued unused vacation from one calendar year may be carried over to the next calendar year. Executive will also be entitled to paid sick leave as provided under applicable law.
5.3Membership Fees. The Company will reimburse Executive for fees and costs associated with business-related memberships and affiliations, gym membership, and social club membership.
5.4Concierge Medical Services. During Executive’s employment with the Company, the Company shall reimburse Executive for the cost of an annual concierge medical services fee and the cost of an annual executive physical. The Company will provide full medical coverage to the Executive’s eligible family members.
6.Business Expenses. Executive will be reimbursed for all reasonable, out-of-pocket business expenses incurred in the performance of Executive’s duties on behalf of the Company, including reasonable out-of-pocket expenses associated with Executive’s professional fees, dues and expenses, and continuing education. To obtain reimbursement, expenses must be submitted on a timely basis with appropriate supporting documentation and will be reimbursed in accordance with the Company’s policies. Any reimbursement Executive is entitled to receive under this Agreement will (a) be paid no later than forty-five (45) days after the date upon which the expense was submitted for reimbursement, (b) not be affected by any other expenses that are eligible for reimbursement in any tax year, and (c) not be subject to liquidation or exchange for another benefit.
7.Termination of Executive’s Employment.
7.1Termination for Cause by the Company. The Company may terminate Executive’s employment immediately at any time for Cause. For purposes of this Agreement, “Cause” is defined as: (a) conviction of or a plea of nolo contendere to any felony or any misdemeanor that involves crimes of moral turpitude, fraud or theft; or (b) the material breach by Executive of any of his obligations, duties and/or covenants under this Agreement if such breach causes material damage to the Company, which breach, if curable, continues following written notice from the Company describing same with particularity and expiration of a sixty (60) day cure period. In the event Executive’s employment is terminated in accordance with this subsection 7.1,
Executive will be entitled to receive only Executive’s base salary then in effect, prorated to the date of termination, and all benefits accrued through the date of termination, including any accrued unused paid time off (collectively, the “Accrued Entitlements”). All other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished upon termination for Cause, and Executive will not be entitled to receive the Severance Benefits described in subsection 7.7 below.
7.2Termination by Executive for Good Reason. Executive may terminate Executive’s employment for Good Reason. For purposes of this Agreement, “Good Reason” shall mean that Executive has complied with the Good Reason Process (hereinafter defined) following the occurrence of any of the following events without Executive’s written consent: (i) a material diminution in Executive’s responsibilities, authority or duties; (ii) a diminution in the Executive’s base salary or target Annual Bonus amount (as determined by the Board in its sole discretion); or (iii) the material breach by the Company of any material provision of this Agreement or other written agreement between the Company and the Executive (each a “Good Reason Condition”). “Good Reason Process” shall mean that (i) Executive reasonably determines in good faith that a Good Reason Condition has occurred; (ii) Executive notifies the Company in writing of the occurrence of a Good Reason Condition within thirty (30) days of the occurrence of such condition (iii) Executive cooperates in good faith with the Company’s efforts, for a period not less than thirty (30) days following such notice (the “Cure Period”), to remedy the condition; (iv) notwithstanding such efforts, the Good Reason Condition continues to exist; and (v) Executive terminates his employment within thirty (30) days after the end of the Cure Period. If the Company cures the Good Reason Condition during the Cure Period, Good Reason shall be deemed not to have occurred.
7.3Termination on Account of Executive’s Death. Upon the death of Executive, the Term shall terminate automatically and all rights of Employee (and Employee’s heirs, executors and administrators) to compensation and other benefits under this Agreement shall cease immediately, except that Employee’s heirs, executors or administrators, as the case may be, shall be entitled to the Accrued Entitlements and to accelerated vesting of any unvested stock or other options. All other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished upon termination, and Executive will not be entitled to receive the Severance Benefits described in subsection 7.7 below.
7.4Termination on Account of Employee’s Disability.
(a)Upon the Company giving Executive written notice of termination for Disability (as herein defined), the Term shall terminate automatically and all rights of Employee to compensation and other benefits under this Agreement shall cease immediately, except that Employee shall be entitled to the Accrued Entitlements and to accelerated vesting of any unvested stock or other options. All other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished upon termination, and Executive will not be entitled to receive the Severance Benefits described in subsection 7.7 below.
(b) “Disability” means Executive’s inability, because of physical or mental incapacity, condition or disability, to perform the essential functions of Executive’s position on a full-time basis, with or without reasonable accommodation, for: (i) 120 consecutive days; or (ii) 180 days (whether or not consecutive) within any rolling 12-month period during the Term.
(c)In the event of any dispute regarding the existence of Executive’s incapacity, condition or disability, the matter shall be resolved by the determination of a physician jointly selected by Executive and the Company. Executive shall submit to appropriate medical examinations and tests for purposes of such determination and shall authorize such physician to release to the Company information regarding any incapacity, condition or disability that could prevent Executive from performing the essential functions of his position on a full-time basis.
7.5Termination by the Company without Cause. The Company may terminate Executive’s employment under this Agreement without Cause at any time on thirty (30) days’ advance written notice to Executive.
7.6Voluntary Resignation by Executive. Executive may voluntarily resign Executive’s position with the Company at any time on thirty (30) days’ advance written notice. The Company reserves the right to release Executive from employment at any time during the thirty (30) day notice period. In the event of Executive’s voluntary resignation, Executive will be entitled to receive only Executive’s Accrued Entitlements for thirty (30) days. All other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished, except any vested stock or other options, treatment of which will be governed by the underlying plan. In addition, Executive will not be entitled to receive the Severance Benefits described in subsection 7.7 below.
7.7Severance Benefits.
(a)In the event of termination of Executive’s employment by the Company without Cause, or by Executive for Good Reason, Executive will receive the Accrued Entitlements and will also receive severance pay equal to (i) three times the amount of Executive’s base salary plus three times the amount of the Annual Bonus payment paid to Executive for the bonus year prior to the year in which Executive’s employment terminates, payable in a lump-sum payment on the first regular payday occurring sixty (60) days following the termination date, and (ii) accelerated vesting of all outstanding options as of the effective date of Executive’s termination (collectively, the “Severance Benefits”).
(b)Notwithstanding anything to the contrary contained in this Agreement, in the event of termination of Executive’s employment pursuant to Section 7.6 (Voluntary Resignation by Executive) or the non-renewal of this Agreement upon expiration of the Initial Term or any Renewal Term, and as a condition precedent to the Covenant Not to Compete set forth in Section 13.2 below, Executive will receive a payment equal to Executive’s then current base salary and target Annual Bonus amount (as determined by the Board in its sole discretion), less applicable withholdings and deductions, payable in a lump-sum payment on the first regular
payday occurring sixty (60) days following the termination date (the “Non-Competition Consideration”).
(c)Notwithstanding the foregoing or anything to the contrary contained in this Agreement, Executive will only receive the Severance Benefits or the Non-Competition Consideration, as applicable, if Executive executes a customary general mutual release in a form reasonably acceptable to the Company and Executive, pursuant to which Executives agrees to release the Company from all claims, known or unknown, arising out of or any way related to Executive’s employment or termination of employment with the Company, and such release has become effective in accordance with its terms prior to the sixtieth (60th) day following the termination date.
8.Resignation of Board or Other Positions. Upon the termination of Executive’s employment for any reason, Executive agrees to immediately resign all other positions (including Board membership) Executive may hold on behalf of the Company.
9.Application of Section 409A.
9.1Notwithstanding anything set forth in this Agreement to the contrary, no amount payable pursuant to this Agreement which constitutes a “deferral of compensation” within the meaning of the Treasury Regulations issued pursuant to Section 409A of the Code (“Section 409A Regulations”) will be paid unless and until Executive has incurred a “separation from service” within the meaning of the Section 409A Regulations. Furthermore, to the extent that Executive is a “specified employee” within the meaning of the Section 409A Regulations as of the date of Executive’s separation from service, no amount that constitutes a deferral of compensation which is payable on account of Executive’s separation from service will be paid to Executive before the date (“Delayed Payment Date”) which is first day of the seventh month after the date of Executive’s separation from service or, if earlier, the date of Executive’s death following such separation from service. All such amounts that would, but for this Section, become payable prior to the Delayed Payment Date will be accumulated and paid on the Delayed Payment Date.
9.2The Company intends that income provided to Executive pursuant to this Agreement will not be subject to taxation under Section 409A of the Code. The provisions of this Agreement will be interpreted and construed in favor of satisfying any applicable requirements of Section 409A of the Code. However, the Company does not guarantee any particular tax effect for income provided to Executive pursuant to this Agreement. In any event, except for the Company’s responsibility to withhold applicable income and employment taxes from compensation paid or provided to Executive, the Company will not be responsible for the payment of any applicable taxes on compensation paid or provided to Executive pursuant to this Agreement. The Parties agree that this Agreement may be amended, as reasonably requested by either Party, to the extent necessary to fully comply with Section 409A of the Code and all related rules and regulations thereunder in order to preserve the payments and benefits provided hereunder without additional cost to either Party.
9.3Notwithstanding anything herein to the contrary, the reimbursement of expenses or in-kind benefits provided pursuant to this Agreement will be subject to the following
conditions: (1) the expenses eligible for reimbursement or in-kind benefits in one taxable year will not affect the expenses eligible for reimbursement or in-kind benefits in any other taxable year; (2) the reimbursement of eligible expenses or in-kind benefits will be made promptly, subject to the Company’s applicable policies, but in no event later than the end of the year after the year in which such expense was incurred; and (3) the right to reimbursement or in-kind benefits will not be subject to liquidation or exchange for another benefit.
9.4For purposes of Section 409A of the Code, the right to a series of installment payments under this Agreement will be treated as a right to a series of separate payments.
10.No Conflict of Interest. During the Term, Executive agrees not to engage in any work, paid or unpaid, or other activities that create a conflict of interest. Such work and/or activities will include, but is not limited to, directly or indirectly competing with the Company in any way, or acting as an officer, director, employee, consultant, stockholder, volunteer, lender, or agent of any business enterprise of the same nature as, or which is in direct competition with, the business in which the Company is now engaged or in which the Company becomes engaged during the term of Executive’s employment with the Company, as may be determined by the Company in its sole discretion. If the Company believes such a conflict exists during the term of this Agreement, the Company may ask Executive to, and Executive will, discontinue the other work and/or activities or resign employment with the Company.
11.Nondisclosure of Confidential Information.
11.1Executive recognizes that the knowledge and information about, and relationships with business associates, customers, clients and agents of the Company and its affiliated companies, and the business methods, systems, plans, and policies of the Company and of its affiliated companies, which Executive may receive, obtain, or establish as an employee of the Company are valuable and unique assets of the Company or its affiliates. Executive agrees that, during any employment period and thereafter, except in the course of performing his duties under this Agreement, Executive will not disclose or remove, without the written consent of the Company, (i) any material or substantial, confidential, or proprietary know-how, data, or information, including, but not limited to software, data, information relating to customers and clients, pricing, training manuals, mandatory processes and means or techniques pertaining to the Company or its affiliates, (ii) any business plans, strategies, targets, or directives, to any person, firm, corporation, or any other entity, for any reason or purpose whatsoever and (iii) any other information deemed by the Company to be confidential, whether marked or otherwise labeled or identified as confidential (collectively, the “Confidential Information”). Executive acknowledges and agrees that all memoranda, notes, records, clients lists, client information and other documents, computer software, data or material or any other Confidential Information in any form made or compiled by Executive or made available to Executive concerning the Company’s business is and will be the Company’s exclusive property and will be delivered by Executive to the Company upon termination of Executive’s employment or at any other time upon the request of the Company.
11.2The restrictions in the above paragraph will not apply to: (1) information that at the time of disclosure is in the public domain through no fault of Executive’s;
(2) information received from a third party outside of the Company that was disclosed without a breach of any confidentiality obligation; (3) information approved for release by written authorization of the Company; or (4) information that may be required by law or an order of any court, agency or proceeding to be disclosed. Executive will provide the Company notice of any such required disclosure once Executive has knowledge of it and will help the Company to the extent reasonable to obtain an appropriate protective order.
11.3The Company acknowledges that Executive has had significant prior work experience in the industry in which the Company is engaged, and that Executive enters into this Agreement with significant prior knowledge, information and relationships in such industry.
12.Company Covenants. As a result of the relationship created further to this Agreement, upon the execution of this Agreement by both Parties, the Company agrees to, and will, place Executive in a position of special trust, and it will provide Executive with: (a) Confidential Information (which includes trade secrets) and access to such information; (b) specialized training, which may include self-study materials, on-line training, on the job training, and instruction as to Company’s products, services, business relationships, and methods of operation; and (c) goodwill support such as expense reimbursements in accordance with Company’s policies, Confidential Information related to Company’s current and prospective clients, customers, business associates, vendors, and suppliers, and contact and relationships with current and potential clients, customers, business associates, vendors, and suppliers to help Executive develop goodwill for the Company. The foregoing is not contingent on Executive’s continued employment for any length of time, but is contingent on Executive’s full compliance with the restrictions in Section 13.
13.Employee Covenants. Executive specifically acknowledges that the items described in Section 12 will be items that Executive has not previously been given, and that Executive would not be given but for the execution of this Agreement. Executive agrees not to, directly or indirectly, participate in the unauthorized use, disclosure, or conversion of any Confidential Information. Specifically, but without limitation, Executive agrees not to use Confidential Information for Executive’s sole benefit, or for the benefit of any person or entity in any way that harms the Company or diminishes the value of the Confidential Information to the Company. Executive also agrees to use the specialized training, goodwill, and contacts developed with the Company’s customers/clients and contractors for the exclusive benefit of the Company, and Executive agrees not to use these items at any time in a way that would harm the business interests of the Company. However, nothing in this Agreement prohibits Executive from reporting possible violations of federal law or regulation to any government agency or entity, making other disclosures that are protected under whistleblower provisions of law, or receiving an award or monetary recovery pursuant to the U.S. Securities and Exchange Commission’s whistleblower program. Executive understands that Executive does not need prior authorization to make such reports or disclosures and is not required to notify the Company if Executive has made or will make any such report or disclosure.
13.1Goodwill with Customers. Executive acknowledges that the Company has near permanent relationships with its customers and owns the goodwill in those relationships with customers that Executive will develop or maintain in the course and scope of Executive’s employment with the Company. If Executive owned goodwill in a relationship with a customer
on the Effective Date, Executive hereby assigns any and all such goodwill to the Company, and the Company will become the owner of such goodwill.
13.2Covenant Not to Compete. In consideration of Executive’s employment with the Company, as well as the Company’s covenants and promises set forth in Section 12 and elsewhere in this Agreement, Executive agrees that, while employed by the Company and during the twelve (12)-month period immediately following the termination of Executive’s employment with the Company, regardless of the reason for such termination (the “Restricted Period”), Executive will not, directly or indirectly render services in the Restricted Territories (whether as owner, operator, member, shareholder, trustee, manager, consultant, strategic partner, employee, or otherwise) that are the same or substantially similar to the services Executive provided to the Company during the 12-month period preceding the end of Executive’s employment, to a Competing Business. For purposes hereof, a “Competing Business” means an entity that provides the same types of services, products, or other offerings as provided by the Company, and “Restricted Territories” means the State of Illinois and the State of New York.
13.3Non-solicitation of Customers. In consideration of Executive’s employment with the Company, as well as the Company’s covenants and promises set forth in Section 12 and elsewhere in this Agreement, Executive agrees that, during the Restricted Period, Executive will not directly or indirectly solicit, cause to be solicited, assist, or otherwise be involved with the solicitation of, for or on behalf of a Competing Business, any persons or entities within the Restricted Territories who are known to Executive as a result of Executive’s employment with the Company, and who were customers or clients of the Company during the twelve (12)-month period preceding the end of Executive’s employment with the Company and about which Executive possesses or received Confidential Information or with whom Executive had substantial personal contact during the period of Executive’s employment.
13.4Non-solicitation of Employees and Contractors. In consideration of Executive’s employment with the Company, as well as the Company’s covenants and promises set forth in Section 12 and elsewhere in this Agreement, Executive agrees that, during the Restricted Period, Executive will not solicit, encourage, or cause others to solicit or encourage any employees or independent contractors of the Company, who are known to Executive as a result of his employment with the Company, to terminate their employment with the Company.
13.5Acknowledgment. Executive acknowledges and agrees that Executive’s services to be rendered to the Company are of a special and unique character, that Executive will obtain knowledge and skill relevant to the Company’s business, its methods, and its strategies by virtue of Executive’s employment, and that the restrictive covenants and other terms and conditions of this Agreement are reasonable and reasonably necessary to protect the legitimate business interests of the Company, including the Company’s trade secrets and other Confidential Information, and are ancillary to the enforceable promises between Executive and the Company in the other sections of this Agreement as well as Executive’s employment with the Company. Executive further acknowledges and agrees that the observance of the covenants set forth herein will not cause Executive undue hardship nor will it unreasonably interfere with Executive’s ability to earn a livelihood either during or following Executive’s employment with the Company. Further, the Parties acknowledge that the foregoing restrictive covenants are essential elements of
this Agreement, and that, but for Executive’s agreement to comply with such covenants, the Company would not have agreed to enter into this Agreement.
13.6Tolling. Executive agrees that if Executive is deemed by a court or other tribunal to have violated any of the terms of the restrictive covenant obligations in this Section 13, the Restricted Period will be extended by one day for each day that Executive failed to comply with the restriction at issue and, further, the Non-Competition Consideration shall cease or be repaid by Executive for each month of such breach during the Restricted Period.
14.Enforcement; Remedies; Construction.
14.1Executive covenants, agrees, and recognizes the breach or threatened breach of the covenants, or any of them, contained in Sections 11, 12 and 13 will result in immediate and irreparable injury to the Company and that the Company will be entitled to an injunction restraining Executive or any of his affiliates from any violation of Sections 11, 12 and 13 to the fullest extent allowed by law. Executive further covenants and agrees that in the event of a violation of any of his respective covenants and agreements contained in Sections 11, 12 and 13 hereof, the Company will be entitled to seek injunctive relief in any court of competent jurisdiction, without the requirement to post bond. Nothing herein will be construed as prohibiting the Company from pursuing any other legal or equitable remedies that may be available to it for any such breach or threatened breach, including but not limited to monetary damages.
14.2Executive hereby expressly acknowledges and agrees as follows:
(a)that he has read the covenants set forth above in Sections 11, 12 and 13, has had an opportunity to discuss them with an attorney and that such covenants are reasonable in all respects and are necessary to protect the legitimate business and competitive interests of the Company; and
(b)that each of the covenants set forth in Sections 11, 12 and 13 and the subdivisions thereof are separately and independently given, and each such covenant is intended to be enforceable separately and independently of the other such covenants, including, without limitation, enforcement by injunction without the necessity of proving actual damages or posting any bond or other security; provided, however, that the invalidity or unenforceability of this Agreement in any respect will not affect the validity or enforceability of this Agreement in any other respect. In the event that any provision of this Agreement is held invalid or unenforceable by a court of competent jurisdiction by reason of the geographic or business scope or the duration thereof or for any other reason, such invalidity or unenforceability will attach only to the particular aspect of such provision found invalid or unenforceable as applied and will not affect or render invalid or unenforceable any other provision of this Agreement or the enforcement of such provision in other circumstances, and, to the fullest extent permitted by law, this Agreement will be construed as if the geographic or business scope or the duration of such provision or other basis on which such provision has been challenged had been more narrowly drafted so as not to be invalid or unenforceable.
14.3Nothing in Sections 10, 12 and 13 will prohibit Executive from being (i) a stockholder in a mutual fund or a diversified investment company or (ii) an owner of not more
than two percent (2%) of the outstanding stock of any class of a corporation, any securities of which are publicly traded, so long as Executive has no active participation in the business of such corporation.
15.General Provisions.
15.1Successors and Assigns. The rights and obligations of the Company under this Agreement will inure to the benefit of and will be binding upon the successors and assigns of the Company. Executive will not be entitled to assign any of Executive’s rights or obligations under this Agreement.
15.2Waiver. Either party’s failure to enforce any provision of this Agreement will not in any way be construed as a waiver of any such provision, or prevent that party thereafter from enforcing each and every other provision of this Agreement.
15.3Attorneys’ Fees. In the event of litigation between the Parties with respect to this Agreement or the interpretation or enforcement hereof, the non-prevailing party shall pay the reasonable legal fees and expenses of the prevailing arty, in addition to such other damages as may be awarded.
15.4Severability. In the event any provision of this Agreement is found to be unenforceable by a court of competent jurisdiction, such provision will be deemed modified to the extent necessary to allow enforceability of the provision as so limited, it being intended that the Parties will receive the benefit contemplated herein to the fullest extent permitted by law. If a deemed modification is not satisfactory in the judgment of such court, the unenforceable provision will be deemed deleted, and the validity and enforceability of the remaining provisions will not be affected thereby.
15.5Interpretation; Construction. The headings set forth in this Agreement are for convenience only and will not be used in interpreting this Agreement. This Agreement has been drafted by legal counsel representing the Company, but Executive has participated in the negotiation of its terms. Furthermore, Executive acknowledges that Executive has had an opportunity to review and revise the Agreement and have it reviewed by legal counsel, if desired, and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party will not be employed in the interpretation of this Agreement.
15.6Governing Law. This Agreement will be governed by and construed in accordance with the laws of the United States and the State of Delaware. Each Party consents to the jurisdiction and venue of the chancery, state or federal courts of Delaware, if applicable, in any action, suit, or proceeding arising out of or relating to this Agreement.
15.7Notices. Any notice required or permitted by this Agreement will be in writing and will be delivered as follows with notice deemed given as indicated: (a) by personal delivery when delivered personally; (b) by overnight courier upon written verification of receipt; (c) by telecopy or facsimile transmission upon acknowledgment of receipt of electronic transmission; (d) by certified or registered mail, return receipt requested, upon verification of
receipt; or (e) by email, which such notice will be deemed delivered and received upon sending. All notices will be addressed as follows:
EXECUTIVE:
Craig Gould
[* * *]
[* * *]
COMPANY:
Binah Capital Group, Inc.
[Address]
[Email Address]
or at such changed addresses as either Party may designate in writing.
15.8Survival. Sections 7.7 and 9 through 16 of this Agreement will survive Executive’s employment by Company.
16.Entire Agreement. This Agreement constitutes the entire agreement between the Parties relating to this subject matter and supersedes all prior or simultaneous representations, discussions, negotiations, and agreements, whether written or oral. This Agreement may be amended or modified only with the written consent of Executive and the Board. No oral waiver, amendment or modification will be effective under any circumstances whatsoever.
[Signatures appear on following page]
[***] Indicates material that has been excluded from this Exhibit 10.1 because it is not material.
THE PARTIES TO THIS AGREEMENT HAVE READ THE FOREGOING AGREEMENT AND FULLY UNDERSTAND EACH AND EVERY PROVISION CONTAINED HEREIN. WHEREFORE, THE PARTIES HAVE EXECUTED THIS AGREEMENT ON THE DATES SHOWN BELOW.
|
| Craig Gould | |
| | | |
Date: | August 14, 2024 | | /s/ Craig Gould |
| | | Binah Capital Group, Inc. |
| | | |
Date: | August 14, 2024 | | /s/ Daniel Hynes |
| | | Daniel Hynes |
| | | Director |
Exhibit A
Approved Outside Activities
None as of the Effective Date.
Exhibit 10.2
EXECUTIVE EMPLOYMENT AGREEMENT
This Executive Employment Agreement (this “Agreement”) is made as of August 14, 2024 (the “Effective Date”), by and between Binah Capital Group, Inc., a Delaware corporation (the “Company”), and David Shane, an individual (“Executive”). Each of the Company and Executive is a “Party,” and collectively, they are the “Parties.”
WHEREAS, Executive is currently engaged as a consultant of Kingswood Acquisition Corporation (“Kingswood”) and Wentworth Management Services, LLC (“Wentworth”);
WHEREAS, following the closing of the proposed SPAC transaction (the “Closing”), Wentworth is a subsidiary of the Company, which is a successor to Kingswood;
WHEREAS, the Company desires to employ Executive in the position of Chief Financial Officer, and Executive desires to accept such offer;
WHEREAS, as of the Effective Date, the Parties agree that any consulting agreements or similar arrangements between Executive, on the one hand, and Kingswood and Wentworth, on the other hand, will terminate and will no longer remain in effect;
NOW, THEREFORE, in consideration of the mutual promises and agreements contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows commencing on the Effective Date:
1.Employment. The Company hereby employs Executive, and Executive hereby accepts such employment, upon the terms and conditions set forth herein.
2.Duties.
2.1Position. Executive is employed as the Chief Financial Officer of the Company. Executive will report to the Chief Executive Officer (the “CEO”) of the Company and will have the duties and responsibilities assigned by such individual that are consistent with such position. Executive will perform faithfully and diligently all such duties assigned to Executive.
2.2Best Efforts/Full-time. Executive will expend Executive’s best efforts on behalf of the Company and will abide by all of the Company’s policies and by applicable federal, state and local laws, regulations and ordinances. Executive will act in the best interest of the Company at all times. Executive will devote Executive’s full business time and efforts to the performance of Executive’s assigned duties for the Company, unless Executive notifies the CEO in advance of Executive’s intent to engage in other paid work and receives express written consent from such individual to do so. Notwithstanding the foregoing, Executive will be permitted to (i) engage in the activities listed on Exhibit A hereto (as such exhibit may be amended from time to time with the written agreement of Executive and the CEO), and (ii) serve as an outside director on the board of directors for nonprofit or charitable entities or manage Executive’s personal financial and legal affairs; in each case, so long as the foregoing activities are not competitive with the Company and subject to the provisions of Section 10 below.
[***] Indicates material that has been excluded from this Exhibit 10.2 because it is not material.
2.3Work Location. Executive may work remotely from locations in the continental United States.
3.Term. Executive’s employment will commence, and this Agreement will be effective as of the Effective Date and will continue for a term of three (3) years thereafter (the “Initial Term”), unless extended or earlier terminated as provided in this Agreement. At least sixty (60) days prior to the expiration of the Initial Term or Renewal Term (defined below), the Executive shall notify the Board of whether the Executive would like to renew this agreement (the “Renewal Notice”) for a successive one (1) year period following the last day of the Initial Term. The Board will consider whether to offer the Executive an extension under this Agreement (such one-year extension, a “Renewal Term”). If the Board decides in its sole and absolute discretion to approve the Renewal Notice, it will notify the Executive accordingly (the “Renewal Approval”), not less than thirty (30) days prior to the expiration of the Initial Term or Renewal Term, as applicable. Each subsequent Renewal Term will renew, subject to a timely Renewal Notice and Renewal Approval for each additional Renewal Term, on the last day of each Renewal Term (each Renewal Term together with the Initial Term, the “Term”). During any Renewal Term, the terms, conditions and provisions set forth in this Agreement will remain in effect unless modified in accordance with the terms of this Agreement. Notwithstanding the foregoing, Executive’s employment with the Company is at-will and may be terminated at any time, with or without Cause (as defined below) or advance notice, by either Executive or the Company, subject to the provisions regarding termination set forth below in Section 7.
4.Compensation.
4.1Base Salary. As compensation for Executive’s performance of Executive’s duties hereunder, the Company will pay to Executive an annualized salary of $400,000, less applicable withholdings and deductions, payable in accordance with the normal payroll practices of the Company. Beginning in calendar year 2025, the Company’s Compensation Committee will conduct an annual review of Executive’s base salary based on third party comparison data and internal management recommendations. Executive’s base salary may be increased but may not be decreased without Executive’s prior written approval.
4.2Incentive Compensation. Beginning in calendar year 2024, Executive will be eligible to earn an annual incentive bonus, the target amount of which will be a percentage of Executive’s base salary as reasonably determined by the Company’s Compensation Committee (the “Annual Bonus”). The target amount of the Annual Bonus for each calendar year of the Term will be up to 100% of Executive’s base salary based on the actual base salary earned by Executive during such calendar year (the “Target Annual Bonus Amount”); provided, however, that notwithstanding anything to the contrary contained in this Agreement, Executive will receive an Annual Bonus of no less than $350,000 for calendar year 2024, and provided further that Executive may be eligible for an Annual Bonus of up to 200% of Executive’s base salary in effect during the applicable Annual Bonus year, based on Executive’s exceptional performance during such year. Any Annual Bonus will be based on Company performance and Executive’s achievement of certain goals, which will be established in good faith by the Company’s Compensation Committee and the Board of Directors (the “Board”) and communicated to Executive in writing within sixty (60) days after the beginning of each fiscal year. The Annual Bonus payment will be
2
less all required taxes and withholdings and, if earned by Executive, paid out in the next year no later than March 31 of such year following the year for which the bonus is earned. For avoidance of doubt, Executive will be entitled to any Annual Bonus that has been earned with respect to a particular bonus year so long as he is employed on December 31 of such year (regardless of whether he is employed on the date on which such Annual Bonus is actually paid).
4.3Stock Options.
(a)No later than six (6) months after the Closing, the Company will grant Executive nonqualified stock options to purchase 250,000 shares of Common Stock of the Company, subject to any reasonable capitalization adjustments before the date of grant (the “Initial Options”), under the terms of the Company’s 2024 Equity Incentive Plan, as may be amended from time to time (the “Plan”). The Initial Options will be exercisable for a period of ten (10) years, subject to earlier termination in accordance with the option agreement and the Plan. The exercise price of the Initial Options will be equal to the fair market value of the Company’s Common Stock on the date of grant. The vesting schedule of the Initial Options will be as follows: 1/3 of the Initial Options will vest on December 31, 2024, and the remaining 2/3 of the Initial Options ratably on the last day of each calendar month following the initial vesting date through December 31, 2026, based on continued service through each vesting date, with the first such monthly vesting date being on January 31, 2025; provided, however, that the Initial Options will accelerate and be deemed vested in full upon a Change in Control (as defined in the Plan).
(b)On each of the first, second and third anniversaries of the Closing, the Company will grant Executive nonqualified stock options to purchase that number of shares of Common Stock of the Company which have a grant date fair value equal to $350,000, as reasonably determined by the Board (the “Additional Options”), under the terms of the Plan. The Additional Options will be exercisable for a period of ten (10) years, subject to earlier termination in accordance with the option agreement and Plan. The exercise price of the Additional Options will be equal to the fair market value of the Company’s Common Stock on the date of grant. The vesting schedule of the Additional Options will be ratable monthly over three years from the date of the grant, based on continued service through each vesting date; provided, however, that the Additional Options will accelerate and be deemed vested in full upon a Change in Control (as defined in the Plan).
(c)The Initial Options and the Additional Options will be granted pursuant to options award agreements that include a cashless exercise provision.
(d)All options granted by the Company will be forfeited upon Executive’s termination for Cause. All option grants will be subject to the terms of the applicable grant agreement and Plan.
5.Benefits.
5.1Customary Fringe Benefits. Executive will be eligible for all customary and usual fringe benefits generally available to executives of the Company, subject to the terms and conditions of the Company’s benefit plan documents. The Company reserves the right to
3
change or eliminate the fringe benefits on a prospective basis, at any time, effective upon notice to Executive.
5.2Vacation; Sick Leave. Executive will be provided with the greater of (a) four (4) weeks’ paid vacation per calendar year, or (b) such greater amount of paid vacation weeks per calendar year as may be provided for pursuant to the Company’s vacation policy then in effect. Any accrued unused vacation from one calendar year may be carried over to the next calendar year but must be used by the end of the next calendar year. Executive will also be entitled to paid sick leave as provided under applicable law.
6.Business Expenses. Executive will be reimbursed for all reasonable, out-of-pocket business expenses incurred in the performance of Executive’s duties on behalf of the Company, including reasonable out-of-pocket expenses associated with Executive’s professional fees, dues and expenses. To obtain reimbursement, expenses must be submitted on a timely basis with appropriate supporting documentation and will be reimbursed in accordance with the Company’s policies. Any reimbursement Executive is entitled to receive will (a) be paid no later than forty-five (45) days after the date upon which the expense was submitted for reimbursement, (b) not be affected by any other expenses that are eligible for reimbursement in any tax year, and (c) not be subject to liquidation or exchange for another benefit.
7.Termination of Executive’s Employment.
7.1Termination by the Company for Cause. The Company may terminate Executive’s employment immediately at any time for Cause. For purposes of this Agreement, “Cause” is defined as: (a) conviction of or a plea of nolo contendere to any felony or any misdemeanor that involves crimes of moral turpitude, fraud or theft; or (b) the material breach by Executive of any of his obligations, duties and/or covenants under this Agreement if such breach causes material damage to the Company, which breach, if curable, continues following written notice from the Company describing same with particularity and expiration of a thirty (30) day cure period. In the event Executive’s employment is terminated in accordance with this subsection 7.1, Executive will be entitled to receive only Executive’s base salary then in effect, prorated to the date of termination, and all benefits accrued through the date of termination, including any accrued unused paid time off (collectively, the “Accrued Entitlements”). All other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished upon termination for Cause, and Executive will not be entitled to receive the Severance Benefits described in subsection 7.7 below.
7.2Termination by Executive for Good Reason. Executive may terminate Executive’s employment for Good Reason. For purposes of this Agreement, “Good Reason” shall mean that Executive has complied with the Good Reason Process (hereinafter defined) following the occurrence of any of the following events without Executive’s written consent: (i) a material diminution in Executive’s responsibilities, authority or duties; (ii) a diminution in the Executive’s Base Salary or Target Annual Bonus Amount; or (iii) the material breach by the Company of any material provision of this Agreement or other written agreement between the Company and the Executive (each a “Good Reason Condition”). “Good Reason Process” shall mean that (i) Executive reasonably determines in good faith that a Good Reason Condition has occurred; (ii)
4
Executive notifies the Company in writing of the occurrence of a Good Reason Condition within thirty (30) days of the occurrence of such condition (iii) Executive cooperates in good faith with the Company’s efforts, for a period not less than thirty (30) days following such notice (the “Cure Period”), to remedy the condition; (iv) notwithstanding such efforts, the Good Reason Condition continues to exist; and (v) Executive terminates his employment within thirty (30) days after the end of the Cure Period. If the Company cures the Good Reason Condition during the Cure Period, Good Reason shall be deemed not to have occurred.
7.3Termination on Account of Executive’s Death. Upon the death of Executive, the Term shall terminate automatically and all rights of Employee (and Employee’s heirs, executors and administrators) to compensation and other benefits under this Agreement shall cease immediately, except that Employee’s heirs, executors or administrators, as the case may be, shall be entitled only to the Accrued Entitlements. All other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished upon termination, and Executive will not be entitled to receive the Severance Benefits described in subsection 7.7 below. For avoidance of doubt, Executive’s heirs, executors and/or administrators will have the ability to exercise options that have vested prior to Executive’s death during the option’s post-termination exercise period.
7.4Termination on Account of Employee’s Disability.
(a)Upon the Company giving Executive written notice of termination for Disability (as herein defined), the Term shall terminate automatically and all rights of Employee to compensation and other benefits under this Agreement shall cease immediately, except that Employee shall be entitled only to the Accrued Entitlements. All other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished upon termination, and Executive will not be entitled to receive the Severance Benefits described in subsection 7.7 below. For avoidance of doubt, Executive will have the ability to exercise options that have vested prior to his termination for Disability during the option’s post-termination exercise period.
(b) “Disability” means Executive’s inability, because of physical or mental incapacity, condition or disability, to perform the essential functions of Executive’s position on a full-time basis, with or without reasonable accommodation, for: (i) 120 consecutive days; or (ii) 180 days (whether or not consecutive) within any rolling 12-month period during the Term.
(c)In the event of any dispute regarding the existence of Executive’s incapacity, condition or disability, the matter shall be resolved by the determination of a physician jointly selected by Executive and the Company. Executive shall submit to appropriate medical examinations and tests for purposes of such determination and shall authorize such physician to release to the Company information regarding any incapacity, condition or disability that could prevent Executive from performing the essential functions of his position on a full-time basis.
7.5Termination by the Company without Cause. The Company may terminate Executive’s employment under this Agreement without Cause at any time on thirty (30) days’ advance written notice to Executive.
5
7.6Voluntary Resignation by Executive. Executive may voluntarily resign Executive’s position with the Company at any time on thirty (30) days’ advance written notice. The Company reserves the right to release Executive from employment at any time during the thirty (30) day notice period. In the event of Executive’s voluntary resignation, Executive will be entitled to receive only Executive’s Accrued Entitlements for thirty (30) days. All other Company obligations to Executive pursuant to this Agreement will become automatically terminated and completely extinguished. In addition, Executive will not be entitled to receive the Severance Benefits described in subsection 7.7 below.
7.7 | Severance Benefits. |
(a)In the event of termination of Executive’s employment by the Company without Cause, or by Executive for Good Reason, Executive will receive the Accrued Entitlements and will also receive severance pay equal to (i) Executive’s then current base salary and Target Annual Bonus Amounts that would be payable during the greater of (A) the remainder of the Term but for such termination, or (B) the Restricted Period (as defined in Section 13.2), in either case, less applicable withholdings and deductions, and payable in a lump-sum payment on the first regular payday occurring sixty (60) days following the termination date, and (ii) accelerated vesting of all outstanding options as of the effective date of Executive’s termination (collectively, the “Severance Benefits”).
(b)Notwithstanding anything to the contrary contained in this Agreement, in the event of termination of Executive’s employment pursuant to Section 7.6 (Voluntary Resignation by Executive) or the non-renewal of this Agreement upon expiration of the Initial Term or any Renewal Term, and as a condition precedent to the Covenant Not to Compete set forth in Section 13.2 below, Executive will receive a payment equal to Executive’s then current base salary and Target Annual Bonus Amount, less applicable withholdings and deductions, payable in a lump-sum payment on the first regular payday occurring sixty (60) days following the termination date (the “Non-Competition Consideration”).
(c)Notwithstanding the foregoing or anything to the contrary contained in this Agreement, Executive will only receive the Severance Benefits or the Non-Competition Consideration, as applicable, if Executive executes a customary general mutual release in a form reasonably acceptable to the Company and Executive, pursuant to which Executives agrees to release the Company from all claims, known or unknown, arising out of or any way related to Executive’s employment or termination of employment with the Company, and such release has become effective in accordance with its terms prior to the sixtieth (60th) day following the termination date.
8.Resignation of Board or Other Positions. Upon the termination of Executive’s employment for any reason, Executive agrees to immediately resign all other positions (including Board membership) Executive may hold on behalf of the Company.
9.Application of Section 409A.
6
9.1Notwithstanding anything set forth in this Agreement to the contrary, no amount payable pursuant to this Agreement which constitutes a “deferral of compensation” within the meaning of the Treasury Regulations issued pursuant to Section 409A of the Code (“Section 409A Regulations”) will be paid unless and until Executive has incurred a “separation from service” within the meaning of the Section 409A Regulations. Furthermore, to the extent that Executive is a “specified employee” within the meaning of the Section 409A Regulations as of the date of Executive’s separation from service, no amount that constitutes a deferral of compensation which is payable on account of Executive’s separation from service will be paid to Executive before the date (“Delayed Payment Date”) which is first day of the seventh month after the date of Executive’s separation from service or, if earlier, the date of Executive’s death following such separation from service. All such amounts that would, but for this Section, become payable prior to the Delayed Payment Date will be accumulated and paid on the Delayed Payment Date.
9.2The Company intends that income provided to Executive pursuant to this Agreement will not be subject to taxation under Section 409A of the Code. The provisions of this Agreement will be interpreted and construed in favor of satisfying any applicable requirements of Section 409A of the Code. However, the Company does not guarantee any particular tax effect for income provided to Executive pursuant to this Agreement. In any event, except for the Company’s responsibility to withhold applicable income and employment taxes from compensation paid or provided to Executive, the Company will not be responsible for the payment of any applicable taxes on compensation paid or provided to Executive pursuant to this Agreement. The Parties agree that this Agreement may be amended, as reasonably requested by either Party, to the extent necessary to fully comply with Section 409A of the Code and all related rules and regulations thereunder in order to preserve the payments and benefits provided hereunder without additional cost to either Party.
9.3Notwithstanding anything herein to the contrary, the reimbursement of expenses or in-kind benefits provided pursuant to this Agreement will be subject to the following conditions: (1) the expenses eligible for reimbursement or in-kind benefits in one taxable year will not affect the expenses eligible for reimbursement or in-kind benefits in any other taxable year; (2) the reimbursement of eligible expenses or in-kind benefits will be made promptly, subject to the Company’s applicable policies, but in no event later than the end of the year after the year in which such expense was incurred; and (3) the right to reimbursement or in-kind benefits will not be subject to liquidation or exchange for another benefit.
9.4For purposes of Section 409A of the Code, the right to a series of installment payments under this Agreement will be treated as a right to a series of separate payments.
10.No Conflict of Interest. During the Term, Executive agrees not to engage in any work, paid or unpaid, or other activities that create a conflict of interest. Such work and/or activities will include, but is not limited to, directly or indirectly competing with the Company in any way, or acting as an officer, director, employee, consultant, stockholder, volunteer, lender, or agent of any business enterprise of the same nature as, or which is in direct competition with, the business in which the Company is now engaged or in which the Company becomes engaged during the term of Executive’s employment with the Company, as may be reasonably determined by the Company. If the Company believes such a conflict exists during the term of this Agreement, the
7
Company may ask Executive to, and Executive will, discontinue the other work and/or activities or resign employment with the Company.
11.Nondisclosure of Confidential Information.
11.1Executive recognizes that the knowledge and information about, and relationships with business associates, customers, clients and agents of the Company and its affiliated companies, and the business methods, systems, plans, and policies of the Company and of its affiliated companies, which Executive may receive, obtain, or establish as an employee of the Company are valuable and unique assets of the Company or its affiliates. Executive agrees that, during any employment period and thereafter, except in the course of performing his duties under this Agreement, Executive will not disclose or remove, without the written consent of the Company, (i) any material or substantial, confidential, or proprietary know-how, data, or information, including, but not limited to software, data, information relating to customers and clients, pricing, training manuals, mandatory processes and means or techniques pertaining to the Company or its affiliates, (ii) any business plans, strategies, targets, or directives, to any person, firm, corporation, or any other entity, for any reason or purpose whatsoever and (iii) any other information deemed by the Company to be confidential, whether marked or otherwise labeled or identified as confidential (collectively, the “Confidential Information”). Executive acknowledges and agrees that all memoranda, notes, records, clients lists, client information and other documents, computer software, data or material or any other Confidential Information in any form made or compiled by Executive or made available to Executive concerning the Company’s business is and will be the Company’s exclusive property and will be delivered by Executive to the Company upon termination of Executive’s employment or at any other time upon the request of the Company.
11.2The restrictions in the above paragraph will not apply to: (1) information that at the time of disclosure is in the public domain through no fault of Executive’s; (2) information received from a third party outside of the Company that was disclosed without a breach of any confidentiality obligation; (3) information approved for release by written authorization of the Company; or (4) information that may be required by law or an order of any court, agency or proceeding to be disclosed. Executive will provide the Company notice of any such required disclosure once Executive has knowledge of it and will help the Company to the extent reasonable to obtain an appropriate protective order.
11.3The Company acknowledges that Executive has had significant prior work experience in the industry in which the Company is engaged, and that Executive enters into this Agreement with significant prior knowledge, information and relationships in such industry.
12.Company Covenants. As a result of the relationship created further to this Agreement, upon the execution of this Agreement by both Parties, the Company agrees to, and will, place Executive in a position of special trust, and it will provide Executive with: (a) Confidential Information (which includes trade secrets) and access to such information; (b) specialized training, which may include self-study materials, on-line training, on the job training, and instruction as to Company’s products, services, business relationships, and methods of operation; and (c) goodwill support such as expense reimbursements in accordance with
8
Company’s policies, Confidential Information related to Company’s current and prospective clients, customers, business associates, vendors, and suppliers, and contact and relationships with current and potential clients, customers, business associates, vendors, and suppliers to help Executive develop goodwill for the Company. The foregoing is not contingent on Executive’s continued employment for any length of time, but is contingent on Executive’s full compliance with the restrictions in Section 13.
13.Employee Covenants. Executive specifically acknowledges that the items described in Section 12 will be items that Executive has not previously been given, and that Executive would not be given but for the execution of this Agreement. Executive agrees not to, directly or indirectly, participate in the unauthorized use, disclosure, or conversion of any Confidential Information. Specifically, but without limitation, Executive agrees not to use Confidential Information for Executive’s sole benefit, or for the benefit of any person or entity in any way that harms the Company or diminishes the value of the Confidential Information to the Company. Executive also agrees to use the specialized training, goodwill, and contacts developed with the Company’s customers/clients and contractors for the exclusive benefit of the Company, and Executive agrees not to use these items at any time in a way that would harm the business interests of the Company. However, nothing in this Agreement prohibits Executive from reporting possible violations of federal law or regulation to any government agency or entity, making other disclosures that are protected under whistleblower provisions of law, or receiving an award or monetary recovery pursuant to the U.S. Securities and Exchange Commission’s whistleblower program. Executive understands that Executive does not need prior authorization to make such reports or disclosures and is not required to notify the Company if Executive has made or will make any such report or disclosure.
13.1Goodwill with Customers. Executive acknowledges that the Company has near permanent relationships with its customers and owns the goodwill in those relationships with customers that Executive will develop or maintain in the course and scope of Executive’s employment with the Company. If Executive owned goodwill in a relationship with a customer on the Effective Date, Executive hereby assigns any and all such goodwill to the Company, and the Company will become the owner of such goodwill.
13.2Covenant Not to Compete. In consideration of Executive’s employment with the Company, as well as the Company’s covenants and promises set forth in Section 12 and elsewhere in this Agreement, Executive agrees that, while employed by the Company and during the twelve (12)-month period immediately following the termination of Executive’s employment with the Company, regardless of the reason for such termination (the “Restricted Period”), Executive will not, directly or indirectly, render services in the Restricted Territories (whether as owner, operator, member, shareholder, trustee, manager, consultant, strategic partner, employee, or otherwise) that are the same or substantially similar to the services Executive provided to the Company during the 12-month period preceding the end of Executive’s employment, to a Competing Business. For purposes hereof, a “Competing Business” means an entity that provides the same types of services, products, or other offerings as provided by the Company, and “Restricted Territories” means the State of Illinois and the State of New York.
13.3Non-solicitation of Customers. In consideration of Executive’s employment with the Company, as well as the Company’s covenants and promises set forth in
9
Section 12 and elsewhere in this Agreement, Executive agrees that, during the Restricted Period, Executive will not directly or indirectly solicit, cause to be solicited, assist, or otherwise be involved with the solicitation of, for or on behalf of a Competing Business, any persons or entities within the Restricted Territories who are known to Executive as a result of Executive’s employment with the Company, and who were customers or clients of the Company during the twelve (12)-month period preceding the end of Executive’s employment with the Company and about which Executive possesses or received Confidential Information or with whom Executive had substantial personal contact during the period of Executive’s employment.
13.4Non-solicitation of Employees and Contractors. In consideration of Executive’s employment with the Company, as well as the Company’s covenants and promises set forth in Section 12 and elsewhere in this Agreement, Executive agrees that, during the Restricted Period, Executive will not solicit, encourage, or cause others to solicit or encourage any employees or independent contractors of the Company, who are known to Executive as a result of his employment with the Company, to terminate their employment with the Company.
13.5Acknowledgment. Executive acknowledges and agrees that Executive’s services to be rendered to the Company are of a special and unique character, that Executive will obtain knowledge and skill relevant to the Company’s business, its methods, and its strategies by virtue of Executive’s employment, and that the restrictive covenants and other terms and conditions of this Agreement are reasonable and reasonably necessary to protect the legitimate business interests of the Company, including the Company’s trade secrets and other Confidential Information, and are ancillary to the enforceable promises between Executive and the Company in the other sections of this Agreement as well as Executive’s employment with the Company. Executive further acknowledges and agrees that the observance of the covenants set forth herein will not cause Executive undue hardship nor will it unreasonably interfere with Executive’s ability to earn a livelihood either during or following Executive’s employment with the Company. Further, the Parties acknowledge that the foregoing restrictive covenants are essential elements of this Agreement, and that, but for Executive’s agreement to comply with such covenants, the Company would not have agreed to enter into this Agreement.
13.6Tolling. Executive agrees that if Executive is deemed by a court or other tribunal to have violated any of the terms of the restrictive covenant obligations in this Section 13, the Restricted Period will be extended by one day for each day that Executive failed to comply with the restriction at issue and, further, the Non-Competition Consideration shall cease or be repaid by Executive for each month of such breach during the Restricted Period.
14. | Enforcement; Remedies; Construction. |
14.1Executive covenants, agrees, and recognizes the breach or threatened breach of the covenants, or any of them, contained in Sections 11, 12 and 13 will result in immediate and irreparable injury to the Company and that the Company will be entitled to an injunction restraining Executive or any of his affiliates from any violation of Sections 11, 12 and 13 to the fullest extent allowed by law. Executive further covenants and agrees that in the event of a violation of any of his respective covenants and agreements contained in Sections 11, 12 and 13 hereof, the Company will be entitled to seek injunctive relief in any court of competent
10
jurisdiction, without the requirement to post bond. Nothing herein will be construed as prohibiting the Company from pursuing any other legal or equitable remedies that may be available to it for any such breach or threatened breach, including but not limited to monetary damages.
14.2Executive hereby expressly acknowledges and agrees as follows:
(a)that he has read the covenants set forth above in Sections 11, 12 and 13, has had an opportunity to discuss them with an attorney and that such covenants are reasonable in all respects and are necessary to protect the legitimate business and competitive interests of the Company; and
(b)that each of the covenants set forth in Sections 11, 12 and 13 and the subdivisions thereof are separately and independently given, and each such covenant is intended to be enforceable separately and independently of the other such covenants, including, without limitation, enforcement by injunction without the necessity of proving actual damages or posting any bond or other security; provided, however, that the invalidity or unenforceability of this Agreement in any respect will not affect the validity or enforceability of this Agreement in any other respect. In the event that any provision of this Agreement is held invalid or unenforceable by a court of competent jurisdiction by reason of the geographic or business scope or the duration thereof or for any other reason, such invalidity or unenforceability will attach only to the particular aspect of such provision found invalid or unenforceable as applied and will not affect or render invalid or unenforceable any other provision of this Agreement or the enforcement of such provision in other circumstances, and, to the fullest extent permitted by law, this Agreement will be construed as if the geographic or business scope or the duration of such provision or other basis on which such provision has been challenged had been more narrowly drafted so as not to be invalid or unenforceable.
14.3Nothing in Sections 10, 12 or 13 will prohibit Executive from being (i) a stockholder in a mutual fund or a diversified investment company or (ii) an owner of not more than two percent (2%) of the outstanding stock of any class of a corporation, any securities of which are publicly traded, so long as Executive has no active participation in the business of such corporation.
15.D&O Insurance. During the time period in which Executive is employed by the Company and for an appropriate period of time thereafter, the Company will: (a) maintain directors and officers liability insurance coverage which provides coverage to Executive (and the Company’s other officers and directors) in size and scope that is customary for a publicly-traded company in the Company’s business; and (b) provide to Executive, on an annual basis, a copy of the relevant insurance policy along with documentation evidencing that such coverage is in full force and effect.
16.General Provisions.
16.1Successors and Assigns. The rights and obligations of the Company under this Agreement will inure to the benefit of and will be binding upon the successors and assigns of
11
the Company. Executive will not be entitled to assign any of Executive’s rights or obligations under this Agreement.
16.2Waiver. Either party’s failure to enforce any provision of this Agreement will not in any way be construed as a waiver of any such provision, or prevent that party thereafter from enforcing each and every other provision of this Agreement.
16.3Attorneys’ Fees. In the event of litigation between the Parties with respect to this Agreement or the interpretation or enforcement hereof, the non-prevailing party shall pay the reasonable legal fees and expenses of the prevailing party, in addition to such other damages as may be awarded.
16.4Severability. In the event any provision of this Agreement is found to be unenforceable by a court of competent jurisdiction, such provision will be deemed modified to the extent necessary to allow enforceability of the provision as so limited, it being intended that the Parties will receive the benefit contemplated herein to the fullest extent permitted by law. If a deemed modification is not satisfactory in the judgment of such court, the unenforceable provision will be deemed deleted, and the validity and enforceability of the remaining provisions will not be affected thereby.
16.5Interpretation; Construction. The headings set forth in this Agreement are for convenience only and will not be used in interpreting this Agreement. This Agreement has been drafted by legal counsel representing the Company, but Executive has participated in the negotiation of its terms. Furthermore, Executive acknowledges that Executive has had an opportunity to review and revise the Agreement and have it reviewed by legal counsel, if desired, and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party will not be employed in the interpretation of this Agreement.
16.6Governing Law. This Agreement will be governed by and construed in accordance with the laws of the United States and the State of Delaware. Each Party consents to the jurisdiction and venue of the chancery, state or federal courts of Delaware, if applicable, in any action, suit, or proceeding arising out of or relating to this Agreement.
16.7Notices. Any notice required or permitted by this Agreement will be in writing and will be delivered as follows with notice deemed given as indicated: (a) by personal delivery when delivered personally; (b) by overnight courier upon written verification of receipt; (c) by telecopy or facsimile transmission upon acknowledgment of receipt of electronic transmission; (d) by certified or registered mail, return receipt requested, upon verification of receipt; or (e) by email, which such notice will be deemed delivered and received upon sending. All notices will be addressed as follows:
EXECUTIVE:
David Shane
[***]
[***]
12
COMPANY:
Binah Capital Group, Inc.
80 State Street
Albany, NY 12207
or at such changed addresses as either Party may designate in writing.
16.8Survival. Sections 7.7 and 9 through 16 of this Agreement will survive Executive’s employment by Company.
16.9Entire Agreement. This Agreement constitutes the entire agreement between the Parties relating to this subject matter and supersedes all prior or simultaneous representations, discussions, negotiations, and agreements, whether written or oral. This Agreement may be amended or modified only with the written consent of Executive and the CEO. No oral waiver, amendment or modification will be effective under any circumstances whatsoever.
[Signatures appear on following page]
[***] Indicates material that has been excluded from this Exhibit 10.2 because it is not material.
13
THE PARTIES TO THIS AGREEMENT HAVE READ THE FOREGOING AGREEMENT AND FULLY UNDERSTAND EACH AND EVERY PROVISION CONTAINED HEREIN. WHEREFORE, THE PARTIES HAVE EXECUTED THIS AGREEMENT ON THE DATES SHOWN BELOW.
| |
| David Shane | |
| | | | |
Date: | August 14, 2024 | | /s/ David Shane | |
| | | | |
| | | Binah Capital Group, Inc. | |
| | | | |
Date: | August 14, 2024 | | By: | /s/ Daniel Hynes |
| | | Name: | Daniel Hynes |
| | | Title: | Director |
14
Exhibit A
Approved Outside Activities
None as of the Effective Date.
15
EXHIBIT 31.1
CERTIFICATION
PURSUANT TO RULES 13a-14(a) AND 15d-14(a)
UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Craig Gould, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q of Binah Capital Group, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.
Date: August 14, 2024 | By: | /s/ Craig Gould |
| | Craig Gould |
| | Chief Executive Officer |
| | (Principal Executive Officer) |
EXHIBIT 31.2
CERTIFICATION
PURSUANT TO RULES 13a-14(a) AND 15d-14(a)
UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, David Shane, certify that:
1. | I have reviewed this Quarterly Report on Form 10-Q of Binah Capital Group, Inc.; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: |
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.
Date: August 14, 2024 | By: | /s/ David Shane |
| | David Shane |
| | Chief Financial Officer |
| | (Principal Financial and Accounting Officer) |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Binah Capital Group, Inc. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Craig Gould, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: August 14, 2024
| /s/ Craig Gould | |
| Name: | Craig Gould |
| Title: | Chief Executive Officer |
| | (Principal Executive Officer) |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Binah Capital Group, Inc. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, David Shane, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: August 14, 2024
| /s/ David Shane | |
| Name: | David Shane |
| Title: | Chief Financial Officer |
| | (Principal Financial and Accounting Officer) |